Healthcare is a complex environment with multiple stakeholders. To assist in gaining a full perspective, XLerateHealth has assembled a group of mentors from that will help you launch a viable healthcare business:
Chiara Bell is CEO and founder of Careticker. Careticker is the world’s first mobile platform that helps patients plan in advance for a hospital or outpatient procedure. Preventable hospital readmissions are a significant cost to the U.S. health care system, costing an estimated $25 billion annually. With our mobile and unique texting capabilities, Careticker empowers patients to better manage and coordinate their needs immediately at the point of care.
Prior to Careticker, Ms. Bell founded ENURGI, the first on-line marketplace for home health care services. In December 2008, ENURGI was acquired by Univita Health, a private equity backed independent aging platform led by industry leaders Ben lytle and Hugh Lytle.
Ms. Bell is a healthcare industry leader and entrepreneur with an extensive background in skilled nursing and home health care. Prior to founding ENURGI, Ms. Bell worked in post-acute care overseeing mergers and acquisitions, employee relations, subsidiary business development, procurement and contract negotiations.
Ms. Bell earned her J.D from Albany Law School and has a B.A. in American Studies with honors from Fordham University.
Suzanne Bergmeister has fifteen years of experience working with entrepreneurs and start-up companies. She is currently the Entrepreneur-in-Residence at the University of Louisville. In this capacity, she teaches in the Entrepreneurial MBA program, the Professional MBA program, the Global MBA program, and the undergraduate Entrepreneurship Minor. She also mentors all of the MBA and undergraduate Business Plan Competition teams. Suzanne formerly worked in the Private Equity Industry for Fort Washington Investment Advisors, Blue Chip Venture Company, and Chrysalis Ventures.
In 2004, Suzanne founded Sunflower Business Ventures Inc. Sunflower specializes in business consulting and management, education and training, and angel investing activities. She founded the Sunflower Seed Funds as an investment vehicle for not-yet-accredited investors. Suzanne has a BS in Electrical Engineering from Rutgers University, an MS in Electrical Engineering from California State University and an MBA from Cornell University, concentrating in Finance.
Suzanne is the President of Venture Connectors (formerly the Venture Club of Louisville) and is on the Advisory Council for the Purdue Technology Center. She serves on the Board of Directors of the Community Foundation of Louisville, Algood Food Company and several start-ups. She is active with the Leadership Louisville organization and is a graduate of Focus Louisville (‘02), Leadership Louisville (‘05), and Bingham Fellows (‘07).
Colonel Bergmeister is an Air Force reservist with 28 years of service. She began her Air Force career at Edwards Air Force Base in California where she was a Flight Test Engineer on the B-1 Bomber and the B-2 Stealth Bomber, and taught Electronic Warfare Testing at the Air Force Test Pilot School. She is currently still an Air Force Reservist, assigned to the US Air Force Academy in Colorado Springs, Colorado. She lives in St. Matthews with her black lab/shepherd mix Zeus and cat Lola. Suzanne’s son, Karl is at the US Naval Academy in Annapolis, Maryland and hopes to become a Marine.
David Bjork is a healthcare executive who has devoted his professional career to building healthcare information technology and healthcare services organizations that make a difference to the US healthcare system.
Mr. Bjork is Co-founder, President and COO of Telcare, Inc., a company that is transforming diabetes management for individuals living with the disease, their caregivers and their healthcare providers. Telcare has developed a new, innovative platform for self-management that is centered on a wirelessly connected blood glucose meter. The business recently announced a financing led by Sequoia Capital and is poised for rapid growth in an industry that is in serious need of disruptive change and innovation.
Prior to Telcare, Mr. Bjork served as Senior Vice President for PolyMedica Corporation (d.b.a. Liberty Medical), the world’s leading provider of diabetes testing supplies, and was a member of the executive management team at the time of the sale of PolyMedica to Medco Health Solutions. Earlier in his professional career, Mr. Bjork held executive management postions at leading healthcare innovators including IntelliCare, ActiveHealth Management, e-MEDx, and Physician Computer Network (PCN). Mr. Bjork is also presently a partner in Assabet Ventures, a management advisory firm that serves the healthcare sector.
Mr. Bjork graduated from the WSBE Business School at the University of New Hampshire with a dual degree in Business Administration and Economics. He currently serves on boards for several healthcare IT and services companies.
Mr. Bjork lives in Concord, Massachusetts with his wife (Christal) and their three boys.
In his position with the Kentucky Innovation Network (GLI’s EnterpriseCorp), Tendai is focused on the development and acceleration of early-stage startup companies. His responsibilities range from helping entrepreneurs assess their market opportunities to assisting startups through the various phases of the customer development methodology and raising early-stage venture funding. Previously, Tendai worked intrapreneurially to build the sustainability division within Summit Energy, a company acquired by Schneider Electric for $268 million in 2011. A practitioner and evangelist of using “lean startup principals” to uncover venture opportunities, Tendai has spoken on the topic as a featured speaker at Eric Ries’ annual Lean Startup Conference 2012 in San Francisco, Code PaLOUsa Conference 2013 in Louisville, and is a 2013 graduate of Steve Blank’s Lean Launchpad Educators Program held at UC-Berkeley. He has a BS in Chemical Engineering and an MBA in Entrepreneurship, both from the University of Louisville. In addition to being an entrepreneur himself, Tendai is a business coach for the Nucleus Lean Startup Training Program, and the Chair of the Presentation Committee for Venture Connectors while volunteering his time as a mentor at Louisville’s West End School.
Joel’s career spans over 25 years specializing in the management of fast growth startups and small to medium sized businesses. He began his career running a small manufacturing company making precision components for the aircraft industry. The company was sold after tripling its size in just 4 years. Joel then co-founded an investment partnership, Cantor & Coleman that acquired and managed several companies including Hamilton Displays, a manufacturer and service provider to the trade show industry. With a blue chip list of clients such as Eli Lilly and Valvoline, Hamilton grew over 50% in the first year after acquisition and then acquired its largest local competitor the following year. In 1983 Joel moved to Louisville, Kentucky as Executive Vice President of Dr. Bizer’s Vision World, a regional eye care chain. The business grew to comprise 19 locations in four states and was acquired by Eye Care Centers of America in 1998. Joel served as COO of Community Physicians Network before becoming President of the Commercial Division of Darwin Networks. Darwin was one of the largest startups ever launched in the state of Kentucky. Under Joel’s leadership, the commercial division executed a business plan expanding into eight major markets across the United States. In 2003, Joel founded Stonemark Granite, a manufacturer of custom stone countertops serving the home center and kitchen design markets. Stonemark now services 32 Lowe’s Home Center stores and has remained profitable through the recession in the housing industry. In 2012, Joel began working with MD2U, a leader in the medical house call field. Joel is currently the company CFO.
Joel graduated magna cum laude with a BSME from the Vanderbilt University School of Engineering and completed his MBA degree at the Harvard Business School.
Holly Symonds Clark currently serves as Interim Co-Director of the University of Louisville’s Office of Technology Transfer (OTT). While co-directing OTT, Holly manages a full docket of life science research disclosures, involving the review of new technologies, intellectual property protection, technology marketing and license negotiation. Holly also enjoys active membership on the Board of Directors for the Louisville area’s Venture Connectors and on the Planning Committee for the Association of University Technology Managers in the Central Region. Prior to joining OTT in 2006, Holly was a Senior Technology Transfer Specialist within the Technology Transfer Branch of the National Cancer Institute (NCI/NIH). During her eight years with NCI, Holly negotiated collaborative agreements and advised NCI intramural scientists and staff on a wide variety of technology transfer issues, including the implementation of the NIH’s Policy on the Sharing of Model Organisms for Biomedical Research. Holly received her B.S. in Biology/Genetics from the University of Maryland and Ph.D. in Molecular Biology from the University of Pittsburgh. She also completed postdoctoral training in cancer research at Duke University.
Aman Bhandari is currently a Senior Advisor to the Chief Technology Officer in the Office of the Secretary of US Department of Health and Human Services (HHS). Aman works on health innovation policy for HHS CTO Todd Park and also the newly formed Center for Medicare and Medicaid Innovation. Previously he worked at the White House reporting directly to the US CTO, Aneesh Chopra, on a variety of health policy issues (i.e. mobile health, open government) where he promoted national initiatives at the intersection of technology, innovation, data and health – engaging the private sector as well as the traditional players.
He has a PhD in Health Policy and Management from the University of California, Berkeley and a certificate in bioentrepreneurship from the Haas School of Business. He has worked in a variety of public health roles from working in a malaria lab to conducting research in an urban HIV/AIDS clinic to writing case studies on one of the only non-profit medical device manufacturing facilities in the world.
Aman has published in journals ranging from Health Affairs to Innovations in Technology, Governance and Globalization. In the past he has worked at Genentech, the UCSF Institute for Health Policy Studies and served as a Director of the Knowledge and Social Responsibility Program for the National Conference for Community and Justice. He lives in the Washington DC area and can be found on twitter: http://twitter.com/GHideas
Lynn Cooper is the president and CEO of BFW Inc., a Louisville-based manufacturer, marketer and exporter of high-intensity surgical headlight systems. As a small business owner she travels globally to successfully compete with big medical device corporations in more than 30 countries in five continents.
Within the Kentucky business community, Lynn is an active board member of Venture Connectors, Kentucky District Export Council of the US Department of Commerce (DEC), and Dress for Success Louisville. She is also a founding member of Louisville’s Network of Entrepreneurial Women (NEW).
Mark Crane is a Purdue Engineer-turned-entrepreneur who won the 2010 Ernst & Young Entrepreneur of the Year award. Over the past 20 years, Mark has served as a consultant, business coach, or investor to over 100 local startups. He currently serves as Chief Operating Office for Edumedics, an innovative healthcare company headquartered in Louisville. Just prior to joining Edumedics, Mark served as Chief Development Officer for MD2U, a home-based primary care company headquartered in Louisville.
Mark co-founded two sources of funding in the Greater Louisville region: The Sequel Fund (for which he still serves as Chief Administrator), and Enterprise Angels, the largest Angel Investor group in Kentucky. He also serves as a Business Coach for U of L’s Launch It! program.
Mark spent 2000-2010 at the helm of the Enterprise Corp—a virtual Business Accelerator that raised over $120M for its clients. Prior to running the Enterprise Corp, Mark spent 11 years with The Cobb Group—an entrepreneurial success story founded by his mentor Doug Cobb.
Bill currently serves at COO at COO at Renew Recovery, an Opioid Addiction facility that uses Suboxone and patient centered and proven recovery methods to break the addiction cycle.
As Manager of University Commercialization for EnterpriseCorp, William “Bill” Dawson was responsible for aiding in the creation and development of local companies based on University of Louisville IP (Intellectual Property). Bill worked in cooperation with NUCLEUS, University of Louisville’s Life Science and Innovation Center. By providing business development advisory services, resource networking and capital raising aid to early stage organizations, Bill helped build and foster growth in the biotech and high tech local ecosystem emerging from the University.
Prior to joining EnterpriseCorp, Bill worked in the financial services sector with life sciences focused boutique investment banks including Dawson James Securities, Jesup & Lamont and LifeTech Capital, the last of which he was a co-founder. Bill held rolls in capital markets, helping to successfully market numerous banking transactions including private placements, underwritten registered secondary’s, registered directs and initial public offerings. Additionally, Bill worked as a sell side research analyst, holding the title SVP- Life Sciences Research where he was responsible for the preparation and maintenance of institutional research reports covering the small/micro-cap life sciences industry. Bill has degrees in Biochemistry and Business Management from Eckerd College in St. Petersburg, FL.
Ms. Scribner is the CEO of Momentivate, which is a consultancy service that works with Fortune 100 companies and start-ups, specializing in Health and Wellness product development and commercialization, mobile devices/apps, telemedicine, Green IT Strategy, Global Solutions & Business Innovation. Ms. Scribner has extensive experience with Business Development, vendor contract negotiations, securing vendor partnerships along with managing multi-million dollar innovative programs from ideation through product/program development, branding, and marketing.
A true serial entrepreneur, who in addition to forming Momentivate, LCC in 2001, owned/operated Daddy’s Money, LLC. An online upscale boutique that featured exclusive lines from World Renowned designers based in NYC. Daddy’s Money received Global Press & had an extensive list of famous customers. The upscale e-boutique was very successful with rapid customer growth and in 2006. She received the Rising Star Award Small Business 2003 & Female Entrepreneur 2006. Listed as one of the smartest women on Twitter, is a huge proponent of social media.
Ms. Scribner enjoys diving, snowboarding, snow skiing, water skiing, boating, running and biking with her family, which includes seven-year old twin boys.
R. Ted Steinbock, M.D. is a practicing radiologist and President of X-Ray Associates of Louisville PSC with a distinguished career of service to patients, organizations, and the community. Dr. Steinbock has twice been honored with the Louisville Top Doctor award by the Greater Louisville Medical Society. He is on the Board of Directors of the James Graham Brown Foundation, has held academic positions in radiology at Harvard University, the University of New Mexico, and the University of Louisville, and he serves both on the boards and in advisory roles to numerous entrepreneurial companies including medical device, cell therapy, and personalized medicine companies. Dr. Steinbock consults with several organizations in the areas of imaging utilization, risk management, and procedure reimbursement. He is also an avid book collector and published expert in the field of paleopathology.
Dr. Steinbock is on the Radiology Council for the American Heart Association, a past member of the economic council of the Society for Cardiovascular and Interventional Radiology (SCVIR), and served for twelve years as the Chairman of Radiology at Baptist Hospital East. Dr. Steinbock graduated AB Magna cum laude with Highest Honors from Harvard University and MD Magna cum laude from Harvard Medical School, and completed his Radiology Residency at Massachusetts General Hospital. He is Board Certified by the American Board of Radiology, licensed to practice medicine in Kentucky, and currently maintains privileges in diagnostic radiology at Baptist Health Louisville.
Alli is the founder and CEO of Wicked Sheets. In 2012, Alli won the Louisville Venture Connectors “Venture Sharks” pitch competition for Wicked Sheets. She used the $5,000 winnings to fund a trip to the annual North American Menopause Convention where she gained the support of 60 medical professionals specializing in women’s health issues. Alli is also an adjunct professor of Psychology at Bellarmine University, and works as a behavior therapist for children diagnosed along the Autism Spectrum. Alli holds a master’s degree in Psychology from the University of Louisville, is a certified personal trainer, and a recent grad of the Kauffman FastTrac program for Louisville entrepreneurs.
Jackie has over 30 years experience in the healthcare industry and works as a Venture Consultant with start-up organizations. In addition to her role as Chief Operating Officer of XLerateHealth, Jackie is the Vice President of Prenatal Diagnostics at NX PharmaGen and leads Partner Development at THRIVE365, a diabetes start-up company that originated within Kraft Foods.
Previously Jackie worked as an expatriate in the United Kingdom as part of the executive management team for Humana Europe, a subsidiary start-up of Humana. During this time Jackie was responsible for leading the design, sales and launch of a full suite of clinical services for the National Health System. Earlier she was Director of Innovation Enterprises at Humana and worked with companies domestically and internationally to identify opportunities to innovate, design and commercialize new products and services, including Richard Branson’s first healthcare company ‘Virgin Life Care’. Jackie also led the design, launch and operational oversight of Humana’s two signature services – Personal Nurse® and HumanaBeginnings®.
Jackie volunteers her time in the start-up community and has served as a judge for the annual Invention and Innovation Awards competition, the Brown-Forman Cardinal Challenge New Venture Competition and the European MBA challenge. In addition, Jackie is a founding member and is on the Board of Directors of the Network for Entrepreneurial Women (N.E.W.) and is a Kauffman FastTrac Tech Venture business coach.
Willmot is a Master’s prepared Perinatal Clinical Nurse Specialist and holds an MBA from the University of Louisville’s entrepreneurship program, a Master’s of Science from the University of Pittsburgh and a Baccalaureate Nursing degree from Villa Maria College.
Raymond F. Vennare is an accomplished senior executive, entrepreneur and investor with more than two decades of hands-on experience creating, launching and building biotechnology and information technology companies across diverse markets.
Acting on behalf of shareholders, boards of directors and senior executives, Raymond plays a key role in company formation, capitalization, business development and the evaluation and execution of commercialization opportunities. The ultimate objective is to expedite the process from discovery to delivery – pipeline development for biotechnology companies, deal flow for investors, company creation for inventors, strategies for technology transfer and commercialization.
Raymond has served as a board director, board advisor or board observer for diagnostic, therapeutic, medical device and software development companies and is frequently in demand as a speaker on issues related to entrepreneurship, innovation, technology commercialization and strategic thinking.
Currently Raymond is Founder and Principal of the Venture Entrepreneur group which is focused on sourcing novel technologies, and emerging opportunities for investors, inventors and research institutions around which companies can be formed or products developed. Previously, Raymond Co-founded ThermalTherapeutic Systems, Inc. (Medical Device) and served as President, Chief Executive Officer and Board Director. Raymond has also been Chief Executive Officer, ImmunoSite (Diagnostics); Senior Vice President and Chief Information Officer, TissueInformatics (Bioinformatics) and; Partner and President, VS/Interactive (Information Technology).
Prior to joining NX Prenatal, Mr. Brohman held the position of Chief Financial Officer and/or Chief Business Officer at oncology drug development firms Bradmer Pharmaceuticals Inc. [TSX: BMR] and Aptamera, Inc. (private company). As a co-founder of Bradmer, Mr. Brohman guided all aspects of the company’s business operations from its inception in 2005 through 2009. Activities included the licensing of Bradmer’s technology from Duke University, the raising over $35 million in equity financing, and the negotiation of all major vendor contracts and clinical study agreements with leading cancer centers across the US.
While at Aptamera, Mr. Brohman led that company’s fundraising and licensing activities beginning in February 2002 through its successful sale in February 2005 to London-based Antisoma plc. Prior to Aptamera, Mr. Brohman served in a variety of corporate finance and business development roles during an 8-year tenure with Cordis Corp., a multi-billion dollar medical device division of Johnson & Johnson.
A graduate of the University of Notre Dame with a BBA in Finance, Mr. Brohman has over 20 years experience in corporate finance and business development, including 16 years in the medical technology field. Since 1995, Mr. Brohman has specialized in the field of business development, and is a veteran of over 100 mergers, acquisitions, licensing and equity financing deals.
Kerry Byler is a Managing Director of BlueCross BlueShield Venture Partners. Previously, Kerry was with Batterson Venture Partners, where he focused on healthcare services and information technology companies. He was also with Lehman Brothers’ Global Private Equity Group and The Sprout Group, the venture capital affiliate of Donaldson, Lufkin & Jenrette/Credit Suisse. Kerry was a founding angel investor in Nexity Financial Corporation which went public in 2005 and he has founded a number of successful start-ups. He is a graduate of the University of Tennessee with Honors and holds an M.B.A. in Analytic Finance, Entrepreneurship and Strategic Management from the University of Chicago Graduate School of Business.
Carla is Managing Director & CEO of IMC, a global brand licensing and marketing services agency that offers world-class brand strategy, research and analysis, a wealth of potential strategic partners, creative licensing and sourcing deal expertise and comprehensive program management to help its clients innovate Carla also serves as CEO of IMC’s Vibrant Nation division, the leading online network of Gen X + Boomer women that creates influencer marketing campaigns for PR agencies; and its investment, SUM180, an online financial planning service that makes financial planning simple and affordable in the employee benefit market.
Carla started her career at Morgan Stanley & Co. where her responsibilities included new product and market development for Morgan Stanley Capital International, operating out of the company’s London and Geneva offices. She then co-founded a financial advisory and fund administration firm that was acquired in 1998 by a Boston bank now owned by State Street Bank. In 2000, Carla became the founding CEO of Community Foundations of America, Inc. (CFA). With a blue-chip client list of major philanthropy institutions and funders such as the W.K. Kellogg Foundation and the Ford Foundation, and more than 115 community foundations nationwide, CFA was widely recognized for its entrepreneurial drive and innovation, particularly in the areas of nonprofit technology, high net worth donor marketing and strategies for demonstrating accountability. Most recently, Carla served as Assistant Vice President, Strategic Initiatives, University of Louisville, Office of Health Affairs where she was responsible for developing strategic initiatives and working within the School of Medicine, the Hospital and the faculty practice organization to improve strategy development and execution.
Carla graduated Phi Beta Kappa from the University of Michigan with Bachelor of Arts degrees in economics and political science, and she holds an M.B.A. from the University of Chicago. She currently serves as Chair of the Foundation Board of the Jefferson Community and Technical College, in addition to her involvement with several other nonprofit organizations.
Dr. Deschatelets is the Chief Operating Officer of Apellis Pharmaceuticals, a company he founded in Louisville in 2009. Apellis is focused on developing a new class of peptide drugs to the market to address a broad range of chronic inflammatory conditions, with an initial emphasis on asthma, chronic obstructive pulmonary disease (COPD), and Paroxysmal Nocturnal Hemoglobinuria. Prior to Apellis, Dr. Deschatelets founded Potentia in 2001, also acting as its Chief Operating Officer until the acquisition of its ocular drug development program by Alcon in 2009. In addition to overseeing the day-to-day activities of these companies and managing external contracts and collaborations, he is actively involved in overseeing their research and development efforts and supporting all the fundraising and business development work. Scientifically, Dr. Deschatelets has been engaged in state-of-the-art research in the areas of chemistry, nanotechnology, diagnostic and biosensing, and drug development for the last 20 years. Dr. Deschatelets received his Ph.D. in organic chemistry from the University of Montreal and his post-doctoral training in the laboratory of Dr. George Whitesides at Harvard University.
Melea joined the University of Louisville’s Office of Technology Transfer in 2001, and now serves as the Interim Co-Director. In addition to her management duties, Melea leads negotiation of licenses, options, and other agreements for the Office, and provides expertise on negotiating intellectual property clauses in grants and contracts for the University. She also manages post-license follow-up for the Office. In her previous roles in the OTT, she managed a large volume of research disclosures, handling case evaluation, marketing, and most importantly, inventor outreach for the newly formed office. She maintains a small portfolio of inventions. Prior to joining the OTT, she worked for a medical supplies distributor and as an attorney at Frost Brown Todd, PLLC where her practice focused on corporate intellectual property. Ms. East has enjoyed presenting at meetings for Association of University and Technology Managers and Licensing Executive Society and has served as an Adjunct Professor of Law at the University of Louisville Law School. Originally from Louisville, she earned her BBA in Finance from the University of Kentucky, graduating summa cum laude, and her JD from the University of Louisville.
Prior to Chrysalis, Elizabeth worked for Booz Allen Hamilton in New York, NY as a Senior Associate where she led project teams in delivering financial and economic research, analysis and recommendations for clients across a variety of industries including media and communications, banking and insurance. Previously, she worked for Macmillan/McGraw-Hill as a Technical Consultant and for Simon & Schuster as Manager of Intranet Services.
A native of Louisville, she is active in community affairs as a board member and Treasurer of Actors Theatre of Louisville as well as a member of the Advisory Council for the Governor’s School for the Arts. Elizabeth holds a BA from Yale University and an MBA from MIT’s Sloan School of Management.
Prior to joining NX PharmaGen, Dr. Ezrin served as Director and CEO of Bradmer Pharmaceuticals Inc [TSX: BMR], guiding the company’s transfer of its lead brain cancer drug technology from Duke University and the launch of a landmark Phase III trial with that drug. In his role, Dr. Ezrin served as the primary strategic liaison to the FDA, to key vendors, to investors and equity analysts, and to the pre-eminent physicians in the field. Prior to joining Bradmer, Dr. Ezrin served as a Director and Chief Scientific Officer of Cardiome Pharma Corp. [TSX:COM, NASDAQ:CRME], where he played an integral role in the development of the company’s lead drug candidate from early stage clinical trials through strategic partnership and NDA filing. Dr. Ezrin has more than 27 years of experience in research and business development in both the pharmaceutical and biotechnology sectors in the US and Canada. Dr. Ezrin was with Sterling-Winthrop Research Group from 1982 to 1993, after which he joined Glycomed Inc. as Assistant Vice President of Experimental Therapeutics. In 1995, he joined RedCell Inc. as Vice President of Pre-Clinical Development leading to the restructuring of the firm in 1997 through the creation of ConjuChem Inc. At ConjuChem, Dr. Ezrin served as Chief Operating and Scientific Officer. He joined Cardiome Pharma Corp. in 2001 as its Chief Scientific Officer and played a vital role in the successful evolution of the firm to a leading cardiovascular company listed on the TSX and NASDAQ exchanges. Dr. Ezrin is extensively published in numerous scientific journals and holds numerous patents for inventions in the pharmaceutical industry. In addition, he has raised substantial invested capital and facilitated numerous transactions and partnerships in the biotech sector.
Ms Ford, the founder of ConsultCare Partners, LLC is a registered nurse and Certified Coding Specialist (CCS) specializing in hospital compliance, coding and reimbursement. Her clinical experience includes cardiovascular, nephrology and orthopedics. As a consultant, she worked for four national healthcare consulting companies before creating her own. Her 30 years of healthcare experience in both clinical and consulting has enabled her to assist over 80 hospitals to identify and achieve cost savings and improved reimbursement. Her reimbursement experience includes assisting hospitals with compliant coding and billing.
She is frequently interviewed by nationally distributed healthcare journals regarding hospital payment. Most recently she has contributed to healthcare related articles published by The New York Times and The Center for Public Integrity.
She has authored and co-authored articles on coding and reimbursement issues. Her extensive knowledge of healthcare data analytics and Medicare reimbursement makes her an expert speaker on documentation, coding, reimbursement, revenue cycle and Medicare compliance.
She is a graduate of Western Kentucky University and the University of Evansville. She is a member of American Health Information Management Association (AHIMA).
Cedric Francois’ primary areas of expertise are immunology and immune system mediated disease. Cedric Francois received his medical degree from the University of Leuven in Belgium and his Ph.D. in Physiology from the University of Louisville. Following postgraduate training in pediatric and transplant surgery, Dr. Francois was a member of the research team that performed the first successful hand transplantation and of the Louisville Face Transplant Team, whose work supported the first human face transplantation in Lyon, France in 2005. He has published numerous publications and is the principal author on the clinical report of the first four human hand transplantations. He is an inventor on many biotechnology patent applications, including all of Potentia’s and Apellis’ proprietary patent applications. Dr. Francois led Potentia to become the first group to test complement-inhibiting drug candidates for age-related macular degeneration, more than a year before the landmark reports in Science magazine. In May 2010, he joined Apellis as its Chief Executive Officer.
Steve Gohmann has been a faculty member in the Department of Economics in the College of Business at the University of Louisville since 1988. He became the BB&T Professor of Free Enterprise in 2009 and Director of the John H. Schnatter Center for Free Enterprise in 2015.
His research focuses on entrepreneurship, health economics, information technology acceptance, and the economics of beer. He typically examines the influence of policy on individual decisions. In entrepreneurship, his studies show that as economies become freer, the types of industries that develop change and the likelihood of entrepreneurship and economic growth increases. The health economics studies examine how various policies affect insurance costs and also the incentives for individuals to obtain treatment for health related problems. Other health economic studies have examined the influence of policymakers’ self-interest on their votes on health issues. The information technology acceptance studies examine how various contractual and organizational incentives affect both the type of system purchased and the extent to which the system will be used. He is a board member of the Association of Private Enterprise Education and on the editorial board of the Journal of Entrepreneurship and Public Policy.
His primary teaching responsibilities are managerial economics in the MBA program with emphasis on the economics of strategy. He also teaches a course on capitalism and economic freedom and has previously taught labor economics, health economics, econometrics, mathematical economics, and principles of economics at the undergraduate level and health care economics at the graduate level. He has lectured internationally in Germany, Hong Kong, Korea, China, Singapore, Greece, Russia, and Panama. He is a two time recipient of the College of Business researcher award, has been named the outstanding graduate teaching professor, and received the outstanding overall faculty award.
A native of New Albany, Indiana, he received his undergraduate degree in Mathematics and Economics from Indiana University and his PhD in Economics from North Carolina State University. He did post-doctoral work at Duke University.
Dr. Heller is a practicing pediatric radiologist who is experienced in health care industry consulting, investment, and management. He trained at the Mallinckrodt Institute of Radiology, Barnes-Jewish Hospital, Washington University School of Medicine in St. Louis, and he later completed a fellowship at Boston Children’s Hospital, Harvard Medical School. Dr. Heller is an Alpha Omega Alpha graduate of the Northwestern University Feinberg School of Medicine. In addition, he earned an MBA from the Kellogg School of Management at Northwestern University. Dr. Heller currently serves as the chair of pediatric radiology for Advocate Children’s Hospital. His areas of interest include operational strategy and corporate finance.
A results-oriented executive who has led both staff and project teams to exceed goals and objectives. Business leader with a history of achieving sales, promoting change, developing personnel and effectively communicating to a wide variety of audiences. Exceeded expectations in key roles throughout organizations ranging from $35MM to $8B in sales. Demonstrated areas of expertise include:
Strategic Planning, Process Improvement, Corporate Development, Leadership, Personnel Recruitment and Management, Sales, Team Management, Client Service, Change Agent, Coach, Interpersonal Relations, Analytical, Project Management, ACO, PCMH, Patient Centered, Consulting
Specialties: Consumer Engagement, Contract Management, Customer Relations, Employee Benefits Consulting, Financial Management, Innovative, Leadership, Management, Mentoring, Negotiation, Organizational Skills, Pharmacy Benefits Consulting, Presentation Skills, Sales, Sales Coaching, Strategic Planning, Teamwork, Vision, Wellness and Fitness Planning.
Steve is a dynamic, results oriented leader with a proven track record of sustainable performance in high tech industries. His most recent engagement was that of Chief Operating Officer of RentalHouses.com where he helped in the turnaround and sale of the company. He has also assumed leadership roles with Earthlink, Inc. that include Mergers and Acquisitions, Product Development, Business Management and Turnarounds. He utilizes his business acumen, strong operational abilities and customer focus to develop and implement strategic plans that result in profitable market growth. He has developed initial business concepts that have introduced new software products into the market at phenomenal growth rates with enviable operating margins.
His accomplishments include: Co-led the turnaround effort at RentalHouses.com where during his eight month tenure he helped the company triple sales, and listings as well as position the company as the market leader in listings within the top 50 US markets. This led to the company’s sale in January 2007 to Consumer Source, Inc.
Initiated and lead the acquisition of a $7 million anti-spyware software and services company. Established strategic priorities and financial targets and launched four new products in the first sixty days resulting in a profitable $10 million growth business and turnaround.
Led a $210 million Cable Product business. Reduced customer churn by 171 basis points resulting in a savings of $25 million. Initiated “Save the Customer” strategy resulting in a 331% increase in program retention and adding $7.4 million in annual sales.
Launched and managed a new software business by developing and delivering a superior value proposition generating $10 million in new revenues with 95% operating margin in less than one year.
Managed and negotiated a technology purchase that reduced acquisition costs by $1.8 million.
Specialties: General Management, product development, product management, HR, corporate finance, accounting, Mergers & Acquisitions
Dr. Jain is a board certified Gastroenterologist and Hepatologist. He is dedicated to promoting awareness of colon cancer, its incidence, risk factors and ways of prevention and early detection.
He completed his Internal Medicine residency and Fellowship in Gastroenterology at University of Louisville Hospital in Louisville, Kentucky. He is proficient in all fields of Gastroenterology and Hepatology and performs therapeutic and diagnostic endoscopy including colonoscopy, polypectomy, upper endoscopy, biliary and pancreatic endoscopic procedures, as well as capsule endoscopy. He practices medicine in Louisville, Kentucky.
Understanding and promoting change –institutional, organizational, individual – has been the organizing theme of Vaughn Keller’s career. He has worked in health care, social change, and communications as a leader, clinician, and consultant. His graduate studies have led to degrees in systems theory, administration and policy studies, marriage and family therapy, and the creation of development programs for professionals.
Dr. Keller has been the Director of the Health Behavior Laboratory at the University of Miami-Humana Health Services Research Center, Associate Director of the Bayer Institute for Health Care Communication, on the faculties of the University of Miami and Yale Schools of Medicine, Director of Management and Organization Development at the Planned Parenthood Federation of America, a senior consultant with Educational Systems and Designs and coordinator of curriculum and development at the Community Development Foundation. For several years he practiced marriage and family therapy.
He conducts research on education and communication in the health care setting and is a frequent contributor to journals and professional conferences. Current projects include advisory positions to three start-up companies, conducting research on the diffusion of innovation, and executive coaching.
David Kil is the founder and CEO of HealthMantic, focusing on lifestyle-medical informatics and sensor-based health gaming. He is also involved in developing optimization algorithms for messaging and patient engagement at HealthCrowd as part-time CSO. Prior to founding HealthMantic, he was Chief Scientist at SKT Americas and Chief Science Officer at Humana, responsible for the development and deployment of healthcare informatics applications. At SKTA, he founded the iWell project and built an integrated wellness platform consisting of sensors, platform, and informatics. The system underwent a successful clinical trial at PeaceHealth with promising results. At Humana, he led the design and development efforts in enterprise knowledge engine, predictive modeling, and outcomes analytics while working with Samsung on U-Health initiatives. The enterprise insight engine won the best-of-breed technology award from the ComputerWorld magazine. He co-authored a book entitled “Pattern Recognition and Prediction with Applications to Signal Characterization” by Springer-Verlag, published over 30 papers, and holds 9 US patents. He graduated from the University of Illinois at Urbana-Champaign with BSEE/Chemistry (Highest Honor and Bronze Tablet), the Polytechnic University of New York (MSEE), and Arizona State University (MBA).
Thane Kreiner, PhD, is Executive Director of the Center for Science, Technology, and Society at Santa Clara University. The Center’s mission is to accelerate global, innovation-based entrepreneurship in service to humanity. Its signature Global Social Benefit Incubator (GSBI™) program has helped more than 160 socially-minded entrepreneurs build sustainable and scalable ventures that deliver essential goods and services to the poor. Thane was formerly Founder, President, and CEO of PhyloTech, Inc. (now Second Genome), which conducts comprehensive microbial community analysis for human health applications. He was Founder, President, and CEO of Presage Biosciences, Inc., a Seattle-based company dedicated to bringing better cancer drugs to market. Thane was the start-up President and CEO for iZumi Bio, Inc. (now iPierian, a regenerative medicine venture based on the break-through iPSc (induced pluripotent stem cell) technology. Prior to his efforts as a “parallel entrepreneur”, Thane spent 14 years in various senior leadership roles at Affymetrix, Inc., which pioneered the DNA chip industry. Thane currently serves on the Board of Directors for the BioBricks Foundation and as a Board member for Didimi, Inc.. He recently participated in the White House Entrepreneurs in Residence program for the FDA. Thane earned his MBA from the Stanford Graduate School of Business; his PhD in Neurosciences from Stanford University School of Medicine; and his BS in Chemistry from the University of Texas, Austin.
Dr. Laden is a co-founder and Managing Director at TriStar Health Partners, a healthcare and life science-focused venture growth fund. THP is an outgrowth of TriStar Technology Ventures, which Dr. Laden helped start in 2009.
Through his role at TriStar, he serves on the Board of Directors for Cerebrotech, GenomOncology, Molecular Sensing, NuSirt Biopharma and Diagnovus (exited) and is an active board observer for TVA and BioStable. Previously, Dr. Laden served as the Assistant Director in the Office of Technology Transfer and Enterprise Development at Vanderbilt University. That role involved leading various technology transfer functions for Vanderbilt, which included identifying, protecting, marketing and licensing promising new technologies to companies of all stages and sizes, as well as developing collaborative, sponsored R&D and material transfer relationships with industry. He also participated in the office’s venture investment and company formation activities.
Before getting what his family described as “a real job”, Dr. Laden was a postdoctoral researcher in the Department of Biochemistry at Vanderbilt in the lab of Dr. Michael Waterman, where his work focused on structure-function studies of the cytochromes P450. He holds a doctorate in Toxicology from the University of Kentucky, a master’s degree in Environmental and Industrial Health from the University of Michigan and an undergraduate degree in biology from Penn State University.
Mr. Langdon’s background is in corporate and product strategy for technology businesses. He has experience in executive management, business development, marketing and public relations, acquisitions, product management, software architecture and development, project management and digital electronics design.
Langdon was part of a core team of executives that led Efficient Networks from a venture-funded startup in Dallas, into a global, market-leading position in broadband network equipment and software. After a successful initial public offering, Efficient Networks acquired several smaller network technology firms, and was subsequently acquired by Siemens AG.
Mr. Langdon is a board member or advisor for several startups in Louisville, KY, and he serves as an advisory board member or mentor for entrepreneurial support organizations including GLI’s EnterpriseCorp, Venture Connectors, XLerateHealth and the Vogt Awards. He is a graduate of the Vanderbilt University School of Engineering.
Google on “Invented disease management” and the entire first page of “hits” will be Al Lewis. The 9th Annual Report on the Disease Management and Wellness Industries calls him “the leading care management outcomes analyst in the country” and he was recently named one of the unsung heroes changing health care forever.
Al Lewis is founder and President of the Disease Management Purchasing Consortium International, Inc. (DMPC–www.Dismgmt.com) DMPC is by far the leading outcomes measurement evaluator in the field of disease management and wellness for health plans, self-insured employers, states, and brokers seeking valid results measurement.
He also confers the only recognized certifications in two areas. The Consortium website, www.dismgmt.com, lists the 200 people who have earned Critical Outcomes Report Analysis Certification and the 25 employers, health plans and states that have received Savings Measurement Validity certification. http://www.dismgmt.com/certs/cora/honor-roll He also provides and guarantees Letters of Validation for programs that achieve savings when validly measured.
His critically acclaimed category-bestselling book on outcomes measurement, Why Nobody Believes the Numbers, chronicling and exposing the innumeracy of the health management field, was named 2012 healthcare book of the year in Forbes. Al’s co-authored “Is It Time to Re-Examine Workplace Wellness ‘Get Well Quick’ Schemes?” become January’s most tweeted Health Affairs article.
His new radio program, The Big Fix, exploring novel economic policy ideas, is carried on the NPR-affiliate in Washington, DC.
Al holds undergraduate (1978) and law (1982) degrees from Harvard University phi beta kappa and taught economics at Harvard, and is currently a Visiting Scholar in health policy at Brandeis University.
A nationally recognized leader in innovations in health care, Jonathan “Jack” Lord, M.D., became the University of Miami’s Chief Innovation Officer when he returned to his alma mater after three decades in leadership roles that spanned the healthcare spectrum in September 2011. In March 2012, he was named Chief Operating Officer of the Miller School of Medicine and UHealth-University of Miami Health System. He completed a financial turnaround of the Miller School and continues as a Professor of Pathology. A board-certified forensic pathologist who began his medical career in the U.S. Navy and later served as chief operating officer of the American Hospital Association and several biotech companies, Lord was the former chief innovation officer and senior vice president of Humana. During his time at Humana, he created Humana’s Innovation Center, which combines research, technology and consumer experience to promote health and well-being. He also contributed to the field of predictive sciences by using advanced analytics to predict who will become ill in the future and how to prevent disease. Further cementing his ties to UM, he oversaw the creation of the UM/Humana Health Resources Center on the Miller School campus in 2006. Lord also serves or has served as a member of a number of prestigious boards and organizations, including the Centers for Disease Control and Prevention’s Advisory Committee to the Director; the National Advisory Council for Healthcare Research and Quality, which advises the U.S. Secretary of Health and Human Services; and the Joint Commission on Accreditation of Health Care Organizations. He was a member of the President’s Council at UM, an advisory group of some of the University’s most prominent alumni. His previous academic appointments include Dartmouth Medical School, George Washington University and the Eastern Virginia School of Medicine. Dr. Lord serves as the Chair of the Board of Directors of Dexcom, is a Director at Stericycle, and serves on advisory board roles for Serco PLC (UK), Anthelio Health and Third Rock Ventures. He has earned certificates in Governance and Audit from the Harvard Business School.
Elisa has more than 20 years of experience working with multinational healthcare companies, including consultancy, CRO organizations, large pharmaceuticals and start-up medical device companies, in the USA, Belgium, Sweden and P.R. China. She has held numerous business development, clinical research and reimbursement management roles throughout her professional career and has significant experience with assisting medical device companies with creating and implementing regulatory, clinical and reimbursement strategies.
Ken founded FoodCare and leads go-to-market partner programs in our restaurant, healthcare, corporate wellness, and food services businesses. Prior to FoodCare, Ken served as the Chief Executive Officer of Appregatta Technologies, a leading market development services business for technology startups comprising a sales force of over 125 highly experienced business development executives, and full service support for strategic planning, product management and business operations.
Previous to Appregatta, Ken served as a team member of the early cloud computing/SaaS practices at both Accenture and Deloitte. Prior to Accenture, Ken founded and led Sempire Systems, a pioneering enterprise software company in the Governance, Risk and Compliance (GRC) category.
Ken started his career with PricewaterhouseCoopers Consulting in the CRM practice responsible for strategy, process and systems engineering of sales automation, marketing and customer care solutions.
Dr. Marvin is an actively practicing transplant surgeon in Louisville, KY. He is currently the Chief of the Division of Transplantation and Director of Liver Transplantation at Jewish Hospital, and Associate Professor of Surgery at the University of Louisville. Prior to his relocation to Louisville, Dr. Marvin was a liver transplant and hepatobiliary surgeon at Westchester Medical Center, Valhalla, New York. In January, 2007, he co-founded Pronia Medical Systems, LLC, the developer of the FDA-cleared Glucocare IGC System, an insulin-dosing calculator utilized in multiple intensive care units in NY, KY and IN to help manage blood sugar levels in critically ill patients. Current customers include: Memorial Sloan Kettering Cancer Center, Westchester Medical Center, Jewish Hospital (part of KentuckyOne Health and Catholic Health Initiatives), among others.
Dr. Marvin graduated Summa Cum Laude/Phi Beta Kappa from Muhlenberg College, Allentown, Pa in 1988. He then attended Medical School at Columbia University’s College of Physician’s and Surgeons (1988-1992), where he was elected to the Alpha Omega Alpha medical honor society. Following graduation, Dr. Marvin completed a decade of training at Columbia University’s New York Presbyterian Hospital which included surgical internship and residency, three years of basic science research and a two-year multi-organ (kidney, pancreas and liver) transplant fellowship.
Greg Matthews is a group director at WCG, where he advises Global and Fortune 500 healthcare companies on social media, communications and enterprise change management. He is currently focused on understanding physicians’ online behavior, and is the originator of the MDigitalLife project. Greg has also developed a model for teaching business leaders how to activate their professional and personal networks online, and is preparing to publish his first book on the subject.
Sean manages the Kentucky Enterprise Fund, a seed and early stage technology investment fund. Previously, Sean was an Associate with MASA Life Science Ventures Fund (MLSV), where he specialized in investments in new biotechnologies, pharmaceuticals, and medical devices. He holds an M.A. from the Patterson School of Diplomacy at the University of Kentucky and he received a B.A. in History from Centre College in Kentucky.
Mr. Pegues is a seasoned health care expert specializing in strategic marketing, new business development, and strategy formulation and execution. Mr. Pegues has deep experience developing new markets and leading turnarounds and is expert at catalyzing a clear vision for organizations and securing commitment to and vigorous pursuit of that vision. Mr. Pegues has worked for national payers, hospitals, specialty pharmaceuticals, medical management, and health care ventures and is recognized for proven ability to create productive change and profitable growth and to energize entire organizations.
Before joining Coventry, Mr. Pegues was Executive Vice President and Chief Marketing and Sales Officer for CareGuide, Inc., a public disease and care management company, where he had responsibility for driving new revenue growth. Prior to CareGuide, Mr. Pegues founded J Pegues Consulting, where he focused on strategy and new business development for health care and life sciences clients. Prior to that, Mr. Pegues was senior vice president of Philadelphia-based Intracorp (CIGNA), a provider of care management services to 28 million consumers who participated in the company’s programs through employer-sponsored health care, workers’ compensation, and disability insurance programs. There he led corporate marketing and business development and was instrumental in developing and executing key growth strategies that expanded the company’s leadership in providing health and productivity solutions. Mr. Pegues also was general manger of Intracorp’s Health Care strategic business unit and was responsible for its product development, sales and account management, marketing, and operations initiatives for employers, carriers, third-party administrators, unions, state and municipal governments, and managed care organizations.
Prior to Intracorp, Mr. Pegues was chief executive officer of Austin, Texas-based Launch-Sequence, Inc., where he led a business innovation laboratory that helped established companies build new businesses based on digital technology. Mr. Pegues was also vice president of e-business at Humana Inc., in Louisville, Kentucky, where he guided the company’s plan to grow through new, technology-based health care businesses. He also served as vice president of Humana’s strategy, research, and business development, and led several initiatives that resulted in substantial profit and operational improvements. Early in his career, Pegues created strategies that resulted in sales and earnings growth for Providian Corporation, PepsiCo, and clients of Deloitte Consulting.
Mr. Pegues brings more than 25 years of diverse experience, innovation, and leadership capabilities as a mentor for XLerateHealth. A native of Tupelo, Mississippi, Pegues holds a bachelor’s degree from Tulane University and a master’s in business administration from the Freeman Business School at Tulane, where he was recognized with the faculty’s “Outstanding Graduate” award.
David has served as President & CEO of CreoSalus since 2002. For more than 25 years, his career has included significant management roles with large life science (medical device, drug and biotech) companies, as well as starting life science firms and serving on the scientific advisory boards of a number of medical device firms. After founding MedVenture Technology Corporation (an INC. 500 company), David served as its President & CEO from its inception in 1988 through 2001. An Ernst & Young Entrepreneur of the Year Award recipient, David has co-founded other medical device firms including CorNovus, InfraReDx and NexGenics. He has over 40 patents issued or pending and has successfully developed more than fifty life science products. David previously held manufacturing and product development positions at Boston Scientific Corporation and Baxter Healthcare. He is a graduate of Georgia Institute of Technology and Harvard Business School.
Mr. Rand co-founded TriStar Technology Ventures in 2009. Through his role at TriStar, he serves on the Board of Directors for Pathfinder Therapeutics, MedCenterDisplay, Molecular Sensing, Nashville Technology Council, Nashville Entrepreneur Center, Nashville Capital Network, E|Spaces and Bridge Nashville.
Prior to co-founding TriStar, Mr. Rand was the Manager of New Venture Development in Vanderbilt’s Office of Technology Transfer and Enterprise Development. That responsibility included licensing Vanderbilt intellectual property, assisting in the formation of new start-up companies and working with existing start-ups. Since beginning as the Chancellor’s Fund in 2000, Vanderbilt has invested a significant amount of capital into 30 different Vanderbilt-related companies. Mr. Rand was responsible for managing this portfolio and represented Vanderbilt on the boards of five of these companies.
Prior to joining Vanderbilt, Mr. Rand worked in PricewaterhouseCoopers’ valuation group, providing consulting and transaction support services. He received his undergraduate degree from the University of Notre Dame and his MBA from Vanderbilt.
After earning a Computer Science degree from the University of Kentucky, Brian completed his Master’s Degree in Economics. Brian founded his first software company, APAX Software, a web design and mobile app development firm. Brian co-founded the Young Entrepreneurs of Lexington organization in 2008, before founding Awesome Inc, a business accelerator and entrepreneur epicenter in 2009. He was honored as the Lexington Young Entrepreneur of the Year in 2010. Brian also serves as the Entrepreneur in Residence at the University of Kentucky.
A charismatic leader, Craig is a healthcare industry veteran with more than 28 years experience. His passion for practical innovation and drive for performance inspires others to discover market opportunities and create strategies that produce growth.
Craig brings to Nurtur his extensive experience in successfully leading health management companies to execute market expansion strategies. He leads the company’s market-facing teams in developing and cultivating new business opportunities including product strategy, B2B alliances, competitive intelligence, revenue development and consultant relations.
Prior to joining Nurtur, Craig served as the Executive Vice President of Business Development and Marketing for tele-medicine start-up, Carena. For six years prior to Carena, Craig served as Senior Vice President of Strategic Initiatives at Health Dialog, where he was responsible for a broad range of market-facing and product management initiatives including health and wellness, strategic alliances and consultant relations. Other prior experience President & CEO of CareWise, Inc., and co-founder for Health Decisions International and The Center for Corporate Health. Mr. Russell began his career at Xerox as manager of the health management program.
Craig holds a BS in Health Sciences from the University of Maine and graduate level training in Management and Organizational Development from the University of San Francisco. He has published numerous articles and is a frequent speaker at national healthcare conferences including IHPM, NMHCC and DMAA (CCA).
Dr. Rodney Samaan is board-certified Cardiologist in the fields of Internal Medicine, Cardiology, Echocardiography and Nuclear Cardiology. His interdisciplinary training puts him in a unique position to care for teens who have been diagnosed with or are at risk for heart conditions and health problems related to premature poor health (such as hypertension, obesity, type 2 diabetes, chest pain, and sleep apnea).
After completing his residency in internal medicine and pediatrics at Cleveland’s University Hospitals Case Medical Center/Rainbow Babies Children’s Hospital, Dr. Samaan went on to complete a fellowship in cardiology at the prestigious St. Vincent’s Hospital of New York City. In addition to his medical training, Dr. Samaan has been involved in a number of medical research projects and has served as a medical reporting intern for ABC News. He has also performed medical work in South America, the Middle East, and South Africa as well as having had several of his works published in US medical journals (including the Texas Heart Journal). He is a frequent attendee at worldwide cardiology conferences, and he enjoys being able to bring the latest cardiology developments to his patients.
An avid runner, Dr. Samaan has completed three marathons and enjoys blogging about stroke and heart disease prevention in his spare time. He also enjoys swimming, cycling, reading, traveling, and taking an active role in the community in raising awareness on the prevention of disease in adolescents and adults. Dr. Samaan is fluent in Spanish and is proud to serve the Spanish-speaking community.
After providing data management and analytics expertise to The University of Chicago and various Fortune 100 retail companies, Grace founded iGlass Analytics to help healthcare companies reduce administrative costs without sacrificing quality of care through smarter use of their data.
Past projects include design and implementation of an enterprise data warehouse for ANSI X12 data, analysis of care management and claims data to deliver outcomes reporting for the Department of Defense’s TRICARE program, and development of data integration between the Centers for Medicare and Medicaid Services and Accountable Care Organizations.
Originally from the Midwest, Grace received her B.S. from The University of Chicago in Geophysical Sciences and her M.S. from The University of Louisville, Speed School of Engineering.
Currently, Dr.Smith is a healthcare innovator and entrepreneur. Current focus on bringing new health technologies to transform conventional notions of clinical trials and patient registries to meet the changing values of the healthcare system and the empowerment of patients in the process.
Co-founder of largest realt-time community asthma monitoring program in partnership with Propeller Health and the Robert Wood Johnson Foundation. AIRLouisville.com
Trained in cogntive neuroscience and life lessons as a serial entrepreneur in interactive media. Non-profit leadership in the frontiers of exposure medicine and human exposure science.
Public policy and practice leader in smart city technologies as former federal and local innovation leader.Dr. Smith was appointed by Mayor Greg Fischer as the Chief of Metro Louisville Government’s Office of Economic Growth and Innovation in January 2012. In this role, he leads efforts to apply new technologies to improve the quality of life in this community of 1.2 million residents. Ted’s efforts to achieve this goal include the pioneering adoption of Asthmapolis rescue inhalers across Louisville Metro to develop a new, real time understanding of the burden of asthma merging public and private data sources including air quality and traffic. This work won the 2012 IBM Smarter City Challenge. Ted has been recognized by the White House in 2012 as a “Champion of Change” for his efforts to gap- finance technology start-ups as part of the the CMS Advanced Payment Primary Care ACO program. Ted was named one of Government Technology’s “Top 25 Doers, Dreamers and Drivers” for 2013.
Ted also serves as an Executive-in-Residence in the University of Louisville’s College of Business. In that role he has led the development of the Health Sector Management MBA Concentration. This program is the first in the world to offer Michael Porter’s Value-based Healthcare Delivery curriculum as part of an accredited program outside of Harvard Business School. Ted also has an active research program funded by the Kauffman Foundation conducting ground-breaking research on improvements to early stage company Ideation.
Prior to joining city government, he was appointed Senior Advisor on Innovation in Health Information Technology in the Office of the National Coordinator (ONC) of Health IT (HIT) in the U.S. Department of Health and Human Services. In that role, he led several initiatives focused on encouraging innovation in health IT and public private partnerships. He served as technology translation manager for the Strategic Health IT Advanced Research Projects (SHARP) Program. This work focused on deep drivers of HIT adoption and cost. He was also responsible for new approaches to clinical decision support (CDS) applications. He has served as an expert judge for all three Annual Health Data Initiative Forum events organized by the U.S. Chief Technology Officer. In this capacity, he advises applied researchers from the vendor and start-up community as they create new product innovations to be showcased each year in Washington DC.
Ted is an Open Government champion and a former member of the White House Office of Science and Technology (OSTP) Open Government Team. He is a successful online media entrepreneur. His most recent company, MedTrackAlert, provided news about the treatment of chronic disease was acquired by Polaris-backed Health Central Networks in 2008. He holds a bachelor of science in Neuroscience from Allegheny College and a M.A. and Ph.D. in Cognitive Neuroscience from Miami University (OH). Dr Smith completed his post-doctoral studies at MIT in space biomedical measurement and was a Co-Investigator for the Neurolab space shuttle mission. He has served on the National Space Biomedical Research Industry Advisory Board since 2008.
Ward Sparacio has nearly 20 years experience in the medical device and medical imaging industries. Prior to his current work consulting start-up companies in developing their organization and strategy, he has held senior leadership positions, domestic and global, with several healthcare start-up enterprises. With experience ranging from his foundation as a sales executive through his years as a CEO, Ward has devised and executed successful market strategies, built sales and marketing organizations, established strategic partnerships and facilitated several financing and M&A efforts. Ward is a proud believer that the best companies are built with great people who use intuition and creativity in place of abundant resources.
Sukhwant Khanuja is the founder CEO of Carematix Inc. He started the company with a vision for developing remote monitoring solutions which are user friendly and drive “sustained compliance”. Carematix has served multiple stakeholders in healthcare across the world delivering intelligenthealthcare solutions to assist in transforming the business and process of healthcare. He has led key innovations including “personalization of medication delivery” and “predictive models for re-admission”.
A seasoned entrepreneur, prior to Carematix served at McKinsey & Co. where he worked extensively in the areas of strategy and operations, including product development and product strategy. Prior to McKinsey, Dr. Khanuja worked at a Product Design Boutique and at Case New Holland. Dr. Khanuja received his PhD in Mechanical Engineering from Purdue University, MS from University of Notre Dame and BSfrom the Indian Institute of Technology, Kanpur. He has received a number of design excellence awards from the American Society of Mechanical Engineering and has published refereed papers in the area of product development. He was awarded an international design award from ASME for the “Compliant Energetic Chair”. The “Elephant Trunk Robotic Arm” won the best project award and spawned multiple doctoral theses.
Andrew Sykes, Chairman of Health at Work (HAW), is a qualified actuary, a licensed health insurance broker, an HIAA managed health professional and an accomplished speaker on the topic of consumer-directed health care and wellness. He has worked on four continents in these areas having started and run NMG Consultants and Actuaries for 15 years and has consulted with some of the world’s largest companies (including WAWA Inc, Shell Oil, McDonald’s, Nokia, Unilever, BHP Billiton, SAB Miller and many others). He works with school districts, health insurers, banks and any other organizations committed to improving health in America. Andrew served as the Chief Wellness Officer for The Vitality Group before starting Health At Work. Andrew has deep insight and relevant experience in the issues faced by large employers in the private and the public sectors. His particular expertise is in: The design and implementation of consumer directed health plans (having converted more members to these types of plans than any other individual working in the United States consulting market today, as a result of his work in Australia, Singapore and South Africa). The mathematics of wellness, and the design and implementation of measurable and effective wellness programs that link to clients’ vision and strategy. The science of behavior change and the creation and deployment of engagement plans, the tools, and techniques that employers can use to drive high and sustained participation in their wellness programs, the essential but often missing element that drives real success in employee health. The art of communicating health care policy changes to employees, leaving them feeling that their concerns have been heard and addressed and the optimal solution for all has been reached.
Qualifications & Associations
Bachelor of Science Cum Laude (Actuarial Science and Mathematical Statistics)
Fellow of the Faculty of Actuaries
Health Insurance Associate and Managed Health Professional (HIAA)
Associate of the Society of Actuaries of America
Richard joined Chrysalis in 2007, initially as Executive-in-Residence and six months later as Operating Partner. As part of Chrysalis’ hand on approach, he brings operational expertise and assists current portfolio companies within the healthcare and technology sectors.
Richard has over 20 years of experience in healthcare analytics and modeling, health services research, product development and healthcare IT, and has published more than 80 articles in national and industry publications. He was CEO and President of CorSolutions from 2001 to 2005, the nation’s second largest disease management company, until it was acquired by Matria Healthcare. In 2004, he was recognized as one of the top 10 disease management executives by Managed Healthcare Magazine. Prior to CorSolutions, Richard was Vice President for Population Health Improvement at Humana Inc., an internal consulting function that oversaw disease management program development and investments. Previously, he led Wake Forest University Medical Center’s Resource Utilization and Outcomes Management Department in the development of programs to improve efficiency for integrated delivery systems while also serving as Associate Professor of Pathology and as Associate Director of the Health Services Research Center.
Richard has a BA from Wake Forest University, an MA from University of Chicago and an MD from Wake Forest University.
Upon graduating from the United States Naval Academy in 1983, Ruth received her commission as an officer in the US Naval Supply Corps and served for 6 years. During her tenure as an officer, Ruth received numerous leadership awards including Naval Achievement, Naval Commendation medals and Service Warfare Officer Qualification. She joined Johnson and Johnson in 1989 and was recognized for her success by being promoted from night shift production supervisor to plant manager within 3 years. Ruth then moved into research and development roles of increasing responsibility and culminated this phase of her career by successfully bringing the first drug eluting stent to market: CYHPER™. Following this blockbuster global launch, Ruth transferred to strategic portfolio and product marketing. Here she was responsible for sustaining the success of CYPHER™ and orchestrated the global launch of 2nd and 3rd generation drug eluting stents. She also expanded the strategic focus of her company by identifying and championing other percutaneous interventional opportunities: mitral and aortic valve repair and replacement, vein graft stenting, and vulnerable plaque diagnosis with local drug delivery platform design. Ruth now is the President and CEO of Vivorte, Inc.; an orthopedic device commercialization company, focused on bringing innovative orthopedic technologies to market.
Vivorte’s mission is to identify, develop, commercialize & out-license orthopedic devices which address a clear unmet need in markets exceeding $1Billion. We currently have 2 products: a minimally invasive implantable device designed to reduce hip fractures and save lives, and a synthetic/biologic bone void filler which is both strong and remodels quickly.
A patent has been issued for both products and the unique bone void filler received FDA clearance. Vivorte successfully launched the bone void filler last year for trauma and is working to expand clinical indications.
Ms. Kathryn Weaver is an accomplished multidisciplinary healthcare and management information systems professional with greater than 20 years of experience in the public and private sectors at a national and international level. She is highly interested in applying information technology solutions to the challenges of healthcare delivery.
Kathy joined Humana in 2002, as a Strategic Consultant, her work at Humana has primarily been focused on developing technology solutions for clinical areas. Initially, she worked to design Humana’s health coaching clinical application, which evolved into the software system for all of Humana’s clinical programs. She also spent several years with Humana’s first international startup, Humana Europe, to design the clinical program offerings and the technological tools to support those offerings. Since returning from the UK, she has been focused on developing Humana’s Health Information Technology strategy. This included implementing a bi-directional clinical data exchange with providers in Humana’s network to improve information at the point of care to help improve clinical outcomes. Prior to Humana she worked for the State of Delaware, Medicaid Division and was responsible for developing and implementing Medicaid’s first automated health record for patients. She has also spent many years working in large hospital systems such as John’s Hopkins Hospital and small community hospitals such as BayHealth on the Eastern shore of DE.
Kathy holds a bachelor’s degree in nursing from Salisbury University in Maryland and her clinical and management background includes adult oncology, telemetry, home health, and case management.
Vik Chadha is the co-founder of a number of high-tech companies such as Backupify, a leading backup provider for cloud-based data, GlowTouch Technologies, a two-time Inc. 500 software and services company with 800+ employees, and Scalable Ventures, a technology startup investment firm.
He is presently serving as the Executive Vice President of Venture Development for Nucleus, where he is leading a number of commercialization initiatives for the University of Louisville Foundation.
From 2001 to 2010, he was a Managing Director of the Enterprise Corp in Louisville, where he managed a portfolio of over 100 client companies and helped them raise $120 million. Prior to the Enterprise Corp, he worked as the Entrepreneur-in-Residence at bCatalyst, an early-stage business incubator. He started his career working as a consultant for GE Appliances where he was a founding member of their Internet team.
He is a 2006 graduate of the Louisville Healthcare Fellows program, an executive education program – based on Louisville’s health-related economy – that allows rising health-related executives to connect with one another and refine their business acumen.
Vik holds a B.S. degree in Electronics & Communications Engineering from the Manipal Institute of Technology and an M.S. degree in Electrical Engineering (major in Computer Engineering) from Virginia Tech.
Tom Granatir joined the American Board of Medical Specialties (ABMS) in 2010 as Senior Vice-President for Health Policy, Government Affairs, and Strategic Partnerships. He is responsible for state and federal policy and strategic relationships in the private and public sector.
Presently on the Board of the PCPI (formerly Physician Consortium for Performance Improvement) and the Casey Health Institute, an integrative primary care clinic near Washington, DC.
His three decades of experience in health policy have focused on quality and public accountability. He has worked in mental health policy for the State of Illinois; hospital policy for the American Hospital Association, the Health Research and Educational Trust, and the Joint Commission on Accreditation of Healthcare Organizations; long-term care policy for the Health and Medicine Policy Research Group; and public health policy for Humana Inc, both in the US and in the United Kingdom. He has served on the governing boards of the American Health Quality Association, the Institute for Safe Medication Practices, Bridges to Excellence, the National Association of Health Data Organizations, Henry Booth House, a service agency for poor residents of Chicago public housing, and he was a founding board member of US Healthiest, a national alliance to make health and well-being a national priority in industry and government. He has been an examiner for the Malcolm Baldrige National Quality Award Program, a member of the Health Policy Roundtable of the Michael Reese Health Trust and a member of the Institute of Medicine Roundtable on the Promotion of Health Equity and the Elimination of Health Disparities. He was educated at the University of Chicago and taught in its Graduate Program in Health Policy and Administration.
Jan Bruce is a seasoned media entrepreneur with a proven track record in high-growth, emerging businesses and turnarounds. She has consistently anticipated consumer wellness and health trends and has built cutting edge products to satisfy these demands in fitness, alternative medicine, holistic health, personal growth and balanced living. She has a passion for building consumer-facing products that help people make measurable improvements in health, wellness and healthy lifestyle.
Bruce is CEO and co-founder of meQuilibrium, the new digital coaching system for stress, which helps both individuals and corporations achieve measurable results in stress management and wellness. Bruce has identified “stress as the new fat” and notes that it is even trickier than obesity because it “operates more like a ‘silent killer,’ creeping up until it is too late to dial back.”
meQuilibrium provides people with proven, measurable methods to increase their stress resilience and live healthier, more productive and satisfying lives. The company’s product is an online, interactive program that offers personalized support and guidance for people wanting to take charge of their stress. The system offers a next generation blend of web, video and mobile technologies to deliver highly personalized, measurable 360° lifestyle programs. meQuilibrium focuses on the wellness/productivity/personal-growth marketplace which includes both individuals and employers seeking Saas solutions.
Prior to founding meQuilibrium, Bruce was Managing Director and Publisher at Martha Stewart Living’s Whole Living.com/ body+soul magazine, the category leader in wellness and sustainability. Bruce rebranded and relaunched Whole Living/Body+Soul in 2002 and then sold in 2004 to Martha Stewart Living Omnimedia, Inc. At MSLO, she successfully managed the high growth business unit and grew the readership from 200,000 to over 650,000 in four years. Bruce developed the award-winning content strategy for the brand, which now extends across print, digital, satellite radio and VOD.
From 2008-2009, Bruce also directed the wellness franchise at MSLO, with responsibility for strategy, revenue and business development. She built MSLO’s first free-standing, branded portal, WholeLiving.com, a destination site leveraging Mind, Body, Spirit, Wellness and “Green” subject-matter interest among women users and brands/advertisers.
Earlier in her career, Ms. Bruce served as CEO and co-founder of Integrative Medicine Communications, the leading digital brand in science-based complementary medicine, a content development/licensing company. Bruce’s first entrepreneurial venture was as CEO and Publisher, Walking Magazine/Walking Inc., which she turned around and then sold to Cowles Media.
Ms. Bruce is a recognized authority on women’s attitudes towards balanced healthy lifestyle and sustainable living. She is a frequent speaker on media turn-arounds and has been a featured presenter at Advertising Week, The American Magazine Conference, The Deutsche Bank Women on Wall Street conference, Harvard Business School, the LOHAS conference and the Green Business Conference.
A runner, yogi, avid cook, Bruce has been a member of the Guest faculty, Columbia University Publishing Course, graduate level program in digital and print media. She is also Entrepreneur in Residence for Chrysalis Ventures, an early stage venture fund with a focus on health and media technology, and is member of the Board of Directors of American Consolidated Media, publisher of local/community news properties. She is a graduate of Smith College.
Carol McCall is responsible for guiding the development of GNS Healthcare’s strategies and aligning them with key initiatives, investments and offerings.
Carol is a health actuary with a background in innovation, predictive analytics and health services design. Her specialties are creating novel computational approaches that leverage ‘big data’ in healthcare and designing services and business models that expand on the traditional notions of health, care, community and sustainability. Most recently, Carol served as Chief Innovation Officer at Tenzing Health, a subsidiary of Vanguard Health Systems, where she merged creative analytic approaches with innovations in health services that extended the dimensions of care, improved people’s health, and dramatically reduced their healthcare costs.
Prior to joining Tenzing, Carol led the R&D efforts in Humana’s Innovation Center where she pioneered using sophisticated analytic techniques to build a portfolio of prediction, knowledge discovery and simulation models. She also launched Humana’s innovations in personalized medicine and led Humana’s Health Services Research Center (HSRC), emphasizing research in population health, health outcomes, health economics, pharmacovigilance, and the psychology of health behavior change. Carol also helped launch Green Ribbon Health, LLC a Florida-based company creating innovations in health support services for seniors in Tampa, and later served on their Board of Directors.
Carol also served as Humana’s Chief Information Officer and as VP of Pharmacy Management. Outside of Humana, she served as EVP of Managed Care Business Development for Allscripts Healthcare Solutions and as an actuarial consultant for Milliman. Carol served as a member of the National Committee on Vital and Health Statistics (NCVHS), a member of the HSRC’s governing board and as advisor to the HRP Scientific Program Board.
Kapil Parakh is a Johns Hopkins cardiologist with a focus on the intersection of health and technology. He has used a combination of lean sigma, design thinking, and lean startup techniques to create an innovative heart failure program that has improved patient outcomes and lowered costs. This unique approach has been well received at national scientific conferences. Kapil co-founded Health for America, www.healthforamerica.org, to use this approach to transform the health of communities across the country. Kapil has authored over two dozen scientific papers, is board certified in Internal Medicine, Cardiology and Advanced Heart Failure and Transplantation. He holds an MD, MPH and PhD.
Mark Gehring is co-founder and President of Asthmapolis, a company dedicated to improving asthma control and reducing cost using its FDA-cleared inhaler sensors and mobile apps. He has previously served as CEO of three companies: Geometrics, developer of the first commercial 3D radiation treatment planning system, now marketed by Philips and used to plan 25% of the radiation treatments worldwide since the mid-90’s, UltraVisual, a medical imaging (PACS) startup that merged with another startup, Emageon, reached $100M in sales, and went public in 2005, and Sharendipity, a software development environment for non-programmers.
Jitin is Director of Product Innovation at athenahealth. Jitin focuses on cloud-based services that enable interoperability and clinical integration across physician practices, healthcare delivery networks (such as ACOs), and the broader healthcare landscape. He also guides product development and physician performance against Meaningful Use requirements.
Prior to athenahealth, Jitin worked at the Office of the National Coordinator for Health IT (ONC), where he lead the S&I Framework, the Direct Project, and other national initiatives centered on standards for health information exchange. During and after his tenure at ONC, Jitin has been an evangelist for health information exchange standards and the opportunities they create to innovate new products, services and business models. He has been a featured speaker at The Health Tech Innovator’s Workshop, the World Health Congress, and the National eHealth Collaborative.
Jitin has a Bachelor’s degree in Computer Science & Engineering from MIT and an MBA from Harvard Business School.
Based in Miami, Lee is a senior marketing and communications specialist with more than 20 years’ branding, advertising, marketing, consumer insight and CRM experience in Europe, the US and Asian markets. He has previously worked in senior management roles for global brands such as Vodafone and Harrods, and spent five years in Tokyo on the creative agency side operating in the financial services, IT and automotive sectors.
For the last seven years he has specialized in the health sector, leading rebranding, turnaround and consumer engagement projects for organizations including US healthcare giant Humana, global telehealthcare company Tunstall, the University of Miami health system and the UK’s NHS. A leading expert in health behavior change, his exploits saw him inducted into the CorpComms 100 Club, an organization which recognizes the top performing corporate communicators in the UK. He is also a co-founder and managing partner at eleven//social, a creative agency specializing in the healthcare sector.
An entrepreneur at heart, Lee has worked with numerous start-up companies advising them on their product development and go-to-market strategies. He also co-founded the first conveyor-belt sushi bar chain in the UK in 1994. A fluent Japanese speaker, Lee holds a Masters Degree in Oriental Studies (Japanese) from Cambridge University.
In addition to leading Vision Dynamics, Mr. Powers’s background includes 30+ years of diverse product development experience and more than fifty issued patents.
Building smart, cross-functional, fast moving teams that are focused on innovating in ways that benefit the customer is his primary strength. Solving tough problems and product challenges in a new ways is where his passion lies.
Mr. Saunders currently serves as a General Partner of OCA Ventures (Chicago) and is a Founding Partner of Saunders Murdock & Associates (Louisville/Boston), an early stage “super-angel” which specializes in life science and technology investments. Previously, Saunders served as Senior Managing Director of Chrysalis Ventures from 1997 – 2009. In January 2009, he retired from Chrysalis. As an angel investor, Saunders has been an important contributing force behind several healthcare, life science, and technology early stage ventures including: Stonestreet One (acquired by Qualcomm), Sanbolic (acquired by Citrix), Backupify (acquired by Datto), US WorldMeds, Aptamera, Bioscale, Vivorte, Carrot Medical, NxPharmagen, SeIkowave Imaging, Summit BioScience, Boardroom Events, and IMC Licensing, among others. He was a founding board member of MetaCyte Business Lab, a life science incubator at the University of Louisville. He also chaired the Industry Advisory Board for the Computer Engineering and Computer Science Dept. at the University of Louisville’s Speed School of Engineering for several years.
Prior to Chrysalis, Saunders was Senior Vice President and Managing Director for Strategic Planning and Business Development at Providian Capital Management, Inc. from 1993-1997. From 1988 to 1993, he was Managing Director of Saunders Capital Group, Inc., a Boston-based private equity boutique. Saunders began his career in 1978 as a business strategy consultant at The Boston Consulting Group and joined Bain & Co. in 1982, where he became acting Director of Competitive Strategy Analysis. A former Marshall Scholar and Fulbright Scholar, he holds a BA from Stanford University, an MSc from the London School of Economics and an MA from Harvard University.
Lindsey Anna, MPH, is a public health and development professional with over seven years of experience working in global health policy and program implementation. She currently serves as Senior Program Analyst at Social Impact, Inc. Prior to this, she served as a health advisor to OIC International, based in Washington, DC, providing project management and technical support to a $30 million food security and nutrition program in Liberia. Lindsey also worked with Family Health International as a Program Officer for Middle East programs and, from 2009-2010, served as a global health fellow in Uganda providing HIV prevention services to underserved populations. Lindsey also possesses a background in U.S. health policy having previously worked for U.S. Senator Mitch McConnell and the U.S. Department for Health and Human Services.
Lindsey received her MPH from The George Washington University and continues to work in post-conflict and humanitarian settings around the world.
David Edelman is an entrepreneur and patient advocate using social technologies to improve health and happiness. He is Co-Founder of Diabetes Daily, a leading online community and educational platform. He also proudly serves on the board of the Diabetes Hands Foundation, an organization that’s empowering people with diabetes on a global scale.
His other passions include promoting entrepreneurship and economic development in Northeast Ohio. He is on the Executive Committee of the Hebrew Free Loan Association, an organization that has been providing interest-free loans to responsible individuals since 1904.
David has spoken passionately at events on diabetes, health care, and social media. With a sense of humor, he explains how individuals are impacted by and influencing global trends in health and technology. David and his work has been covered in the Wall Street Journal, Chicago Tribune, Diabetes Forecast, Diabetic Living and a wide variety of other publications.
David graduated from Brown University in 2003 with a B.A. in Education.
Marianne H. Hutti, PhD, WHNP-BC, joined the University of Louisville (UofL) faculty in 1979. She is Professor and Coordinator or the Women’s Health-Family Nurse Practitioner Double Major Program at the University of Louisville (UofL) School of Nursing, and currently teaches MSN and PhD students. She was the first Associate Director of the Delphi Center for Teaching and Learning at UofL (2005-2009), where she was responsible for all activities related to teaching the university full and part-time faculty about better teaching pedagogy. She has been an NIH-funded researcher in the area of perinatal/pregnancy loss, and is currently working with a team of nurses from the Norton Healthcare System to investigate the meaning, experiences, and behaviors of nurses caring for families after fetal loss. Dr. Hutti has received national awards as a teacher and researcher, speaks nationally and internationally on women’s health-related topics, and has published numerous articles, particularly in the area of perinatal loss. In addition, she practices one day/week as an independent Women’s Health Nurse Practitioner (WHNP).
Mert Hilmi Iseri is the young turk of design. His journey started off in Istanbul, Turkey and changed courses completely once he arrived at Northwestern’s McCormick School of Engineering. After graduating with his own degree “Entrepreneurial Design” in the spring of 2011, he is excited to embrace design and entrepreneurship to galvanize a generation into positive change. During his time in Northwestern, he co-founded Design for America, a national network of student led design studios working to create social impact. Currently, he is the CEO and co-founder of SwipeSense – a company that aims to save the 100,000 deaths that occur every year in the US due to Hospital-Acquired Infections.
Yuri Frank Maxwell Malina is many things, an entrepreneur, a scientist, a design activist, but most of all, he is an eternal optimist. Born in France, educated in the United States, Yuri has spent his life exposed to different European and American peoples and cultures, and as a result truly feels part of one human family.
Yuri is the Co-Founder of Design for America, a nation-wide initiative to spur local social innovations among college students. He helped grow the organization from 3 students at his university to over 500 spread across the United States. Collectively DFA students design products, services and businesses that tackle a variety of social and environmental challenges.
Alongside DFA Yuri is the co-founder and Chief Operating Officer of SwipeSense, a start-up in the healthcare space which aims to eliminate Hospital-Acquired Infections, a leading cause of death in the US. He studied Physics and Mathematics in the Integrated Science Program (ISP) at Northwestern University, is a member of the Sandbox-Network, and has two patents to his name. He is currently based out of Evanston, IL.
Dr. Jin Lee is currently working at the Innovation Center at Humana as an Emerging Technology Consultant. She primarily vets start-ups from academia and partners with professors from leading universities to accelerate the needs of business in Humana.
Dr. Lee is also the co-founder and VP of Anacrusis Press, a publishing press that partners with schools and NGOs to help young adults write and publish their creative work internationally. Previously, Dr. Lee spent 16 years serving as the executive VP for two Chinese restaurants, 8 years in volunteering and conducting clinical neuroscience research at the Hospital of the University of Pennsylvania and John Radcliffe Hospital at the University of Oxford, where she co-supervised various independent student projects.
Dr. Lee has a BA in Biology and Neuroscience from the University of Pennsylvania and a Ph.D in Experimental Psychology from the University of Oxford where she was a Thouron Fellow.
Dr. Troy Koch joined Hobart in 2011 as Senior Vice President, Director of Client Services and is responsible for the strategic direction and growth of Hobart Core, a managed markets focused marketing and communications agency within Hobart Group Holdings. Before joining Hobart, Troy was responsible for Business Development the health economics and outcomes research firm, Competitive Health Analytics, a business entity within Humana, where he was responsible for executing the business growth strategy for the company, identifying new clients, and increasing revenue from existing research partners.
Prior to Competitive Health Analytics, Troy built a successful account management team for the pharmacy benefits manager Humana Pharmacy Solutions. His team was responsible for pharmacy benefit consultation, client retention, and the upsell of client services to large national accounts. In addition, he was responsible for the development of the marketing strategy for Humana Pharmacy Solutions.
Prior to his tenure with Humana, Troy served in various leadership roles, including the Director of Pharmacy for a large state Medicaid program, as well as business development and product development roles with CorSolutions, a national disease management company.
Troy earned his Doctor of Pharmacy degree from the University of Kentucky and earned a Master of Business Administration degree with distinction from the University of Louisville. In addition, he completed a postgraduate residency in managed care pharmacy with Humana Inc.
Benjamin W. Murcek, D.O., FAOCO, is a board certified otolaryngologist, head and neck surgeon who practices is in Sandusky, OH. Dr. Murcek is a founding member and currently chair of the board of directors of Northern Ohio Medical Specialists (NOMS). NOMS is a multispecialty group medical practice based in Sandusky, OH with approximately 50 physician members and 10 midlevel providers. NOMS was recently awarded ACO status by CMS and is one of only 3 ACOs in northern Ohio.
Dr. Murcek relocated to Sandusky after completing his residency in 1992. He has a particular interest in the treatment of head and neck cancer as well as surgical disease of the thyroid and parathyroid. Dr. Murcek is actively involved in medical education, training medical students, interns and residents. He has garnered many awards for his clinical teaching including Master Clinical Faculty from the Ohio University Heritage College of Osteopathic Medicine. Additionally, Dr. Murcek sits on the American Osteopathic Association’s Bureau of Osteopathic Specialists and is chairman of the American Osteopathic Board of Ophthalmology, Otolaryngology, Head and Neck Surgery.
Dr. Murcek and a colleague founded the Northern Ohio Surgical Center, a free -standing outpatient surgery center in Sandusky, OH. The center has been the centerpiece of many publications in the industry, setting an example for safety, patient satisfaction and economic success. It has also served as an avenue to partner with the local hospital in an effort to provide the best service for the region’s patients and surgeons as well. He is currently a member of the physician management group that oversees the day-to-day operations of the center.
Dr. Murcek is very interested in the rapidly changing health care delivery environment. His involvement with NOMS, the surgery center as well as his active participation at the national level with the AOA gives him a unique perspective as a practicing physician surgeon as well as entrepreneur.
Brian Norris is an experienced healthcare clinician, executive and innovator. He has held various executive, clinical, consulting and technology roles within several of today’s largest healthcare and consulting institutions. Brian has led HealthIT initiatives in the hundreds of millions of dollars. He is a recognized as a leader in informatics, and his work has been recognized in many forums including citations in HealthcareIT News, Med City News, Bloomberg Business Week, Government HealthIT, and others.
Brian currently serves as CEO and Cofounder of Social Health Insights LLC an organization developing healthcare analytic, social media analytic and social technologies to solve today’s toughest healthcare problems. Social Health Insights recently won the NowTrending2012 challenge sponsored by the Assistant Secretary for Preparedness and Response (ASPR) under Health and Human Services(HHS). The winning application, MappyHealth has been cited in various media outlets including HealthIT News, Government HealthIT, Modern Healthcare, Health and Human Services, Information Week, Business Week and several others. In addition to this challenge Brian lead his team to develop a redesign of BlueButton for an innovation health design challenge which was included in a showcase cited as “an entry that inspired the judges and challenged the status quo”.
Brian serves on the Indiana HIMSS board of directs and holds a Masters of Business Administration in Healthcare Management from Indiana Wesleyan University, Bachelors in General Studies from Indiana University, and Associate in Science and Nursing from Purdue University. He is licensed as a Registered Nurse in Indiana and Texas and holds board certification from the ANCC in Informatics.
Eve is an experienced Silicon Valley product builder, entrepreneur and investor with expertise in assembling diverse teams to solve hard problems. Eve started her career as a product manager at Trilogy, an enterprise ecommerce software company, working on new ventures. From there, Eve held product, strategy and business development roles in software and internet businesses including Microsoft, Zazzle and eCert. Eve has also been a member of the investment teams at Amadeus Capital Partners, Vector Capital, and Greylock Partners. Prior to co-founding Empower, Eve was a Research Affiliate in the Synthetic Neurobiology Group at the MIT Media Lab. Eve holds an MBA from Stanford University and an SB and an M.Eng in Computer Science from the Massachusetts Institute of Technology.
Viji Sundar has 18+ years of experience as an IT professional with Fortune 500 companies such as Bristol Myers Squibb, Kraft Foods and Humana Inc. She currently leads the Enterprise Solution Architecture team with Humana Inc., where she excels in delivering robust Application, Business, and Information Technology Architecture solutions on several multi-million dollar Healthcare initiatives across the enterprise.
She holds an MBA in Entrepreneurship from University of Louisville and a Master of Management Studies degree from Birla Institute of Technology and Science, India. Ms. Sundar quenches her passion for entrepreneurship by serving as an advisor and strategic partner on various small business ventures.
Dallas is a seasoned healthcare executive with over 30 years of domestic and international healthcare experience working in virtually every delivery spoke of the health care system, including hands-on operational experience in insurance, HMOs, government audits, hospital and clinical operations and research as well as having hands-on experience in the health care lobbying process in Washington DC. This multi-dimensional view of the various delivery elements has given her the unique ability to impact troubled companies or start up operations that yearn for a teacher, educator and a builder of processes and relationships.
Dallas joined Humana as a Business Development Director, responsible for “boots-on-the ground” to build out new product initiatives, including Humana’s first subsidiary in the United Kingdom to deliver competitive administrative services to the UK’s National Health Services Department. She has extensive experience managing the bidding, contracting, financial operations and strategies for submission of key government bids both domestically and internationally.
Dallas’ CFO and Senior VP roles with American Hospital Association (AHA), provided a great opportunity to redirect a national strategy, rebuild financial systems and expand her relationships with regional CEOs, while conducting local Executive Board presentations and education on US health policy and industry issues.
Dallas began her career working for Blue Cross and Blue Shield, Illinois (BCBSI) as an auditor, ensuring hospital compliance with Medicare and Medicaid reporting. Several of her audit findings and fraud reports resulted in Senate Subcommittee oversight and legislative changes. She was promoted within internal operations and was responsible for the team’s implementation of a new internal cost accounting system supporting the underwriting and pricing for all of BCBSI clients.
In the 1990’s, Dallas joined a start-up Health Maintenance Organization (HMO) which was a joint venture capitalized by 40 hospitals in the Chicago area. As the CFO, she supervised several Physician Groups (IPAs), implemented policies, procedures and all aspects of finance, accounting, underwriting, and technology services for new delivery systems.
Following the HMO experience, she was invited to join a newly formed executive management team established to save a struggling community hospital from the brink of bankruptcy and to rebuild the hospital services in collaboration with The University of Chicago Hospitals’ world class “Centers of Excellence” clinical programs. In her role as the CFO and later as the Senior Vice President of Clinical Operations, Dallas gained turn-around experience in executing reductions-in–force, establishing performance measurements and annual customer satisfaction surveys with measurable goals and pay-for-performance scores and building consensus around a long term strategic plan and missions.
In addition to her full-time career, she worked part time for 13 years as an instructor for the Becker CPA Review course, coaching professionals in preparation for the CPA exam in Illinois. With a class size of 200 to 300 students per season, she consistently achieved top 10 ranking of over 400 instructors, nationally.
Dallas stays active doing financial volunteer work and currently resides in Bradenton, Florida. She earned her BBA in Accounting from Loyola University in Chicago, and her MBA from the University of Chicago. She holds her CPA certificate and was a licensed CPA in the state of Illinois.
Dr. Ikeguchi is a board certified urologist trained at Columbia Physicians and Surgeons. After completing residency in general surgery and urology followed by fellowship in neurourology, he remained in academic practice with Columbia University until founding Internet technology company OceanTek in 1995, which specialized in creating software products for web security and social media.
In 1999 after a successful exit from OceanTek, with the same team, he co-founded medical informatics company Medidata Solutions, focusing on applying web-based systems to the pharmaceutical industry and the drug-development life cycle. Initially as CEO and subsequently as CMO, he grew the company through its early stages, developing sales, service and regulatory compliance operations. Later in his involvement he grew the company’s market presence to leadership positions in Europe, Japan and China. Medidata Solutions successfully completed its initial public offering in June 2009 (NASDAQ: MDSO).
Dr. Ikeguchi has since retired from the board of Medidata Solutions and continues to pursue the entrepreneurial spirit. He remains active in the pharmaceutical R&D space and medical informatics. He has also returned to school with the Berklee College of Music.
Dr. Stuart Williams received his Ph.D. in cell biology from the University of Delaware, followed by postdoctoral training in pathology at the Yale School of Medicine. During the period 1980 to 1990 he held a faculty appointment at Jefferson Medical College, where he was director of research in the department of surgery. In 1990 Dr. Williams joined the faculty at the University of Arizona and established the section of surgical research in the department of surgery. In 1997 he founded the University of Arizona biomedical engineering program, creating a research and educational link between the medical school and the college of engineering. He held faculty positions jointly in biomedical engineering, surgery, physiology and materials science and engineering.
In 2007 Dr. Williams was selected as the scientific director of the newly established Cardiovascular Innovation Institute, a partnership between Jewish Hospital and the University of Louisville in Louisville Kentucky. Dr. Williams’ research interests have focused on medical devices, regenerative medicine and infection control. He developed and patented the first methods to use fat-derived stem cells for therapeutic use. He has maintained continuous funding from the National Institutes of Health since 1979.
Dr. Williams has authored over 300 scientific publications. His entrepreneurial spirit has resulted in 16 issued US patents with numerous patents pending. He has founded three biotechnology companies, maintained active managerial positions and has been an active consultant to the medical device and pharmaceutical community. He is a fellow of the American Heart Association and a fellow of the American Institute of Medical and Biological Engineering.
Stephen Hall (Steve) is a Registered Patent Attorney with Wyatt, Tarrant & Combs in Louisville. He helps clients create, protect, and realize value from their patents and other intellectual property, in the areas of medical devices, biotechnology, microelectromechanical systems, software, and chemical inventions. Steve takes an integrated approach in helping clients make decisions and take action based on the big picture. He is recognized by Best Lawyers in Biotechnology Law and by Chambers USA. He is a frequent lecturer and published author.
Following an early career at Baxter, International, ending up as a division General Manager. Henry Kuehn spent the next 30 years as CEO of venture backed companies in the medical and healthcare industry. Beginning with Smith Laboratories, where guided the company through the FDA approval of a new pharmaceutical product and a successful IPO, he went on to manage companies that include Ryan Medical, Ring Medical, Fischer Imaging, GenDerm Pharmaceuticals, and InX Medical. Each of these was either a start up or floundering enterprise needing significant new direction.
He currently serves on two corporate boards and is an advisor to start up enterprises emerging from the University of Louisville medical center. He is a past trustee of Saint Mary of the Woods College and has served on the national executive committee of the Yale Science and Engineering Association. He is a life trustee and past board chair of the Chicago Architecture Foundation. Other organizations with which he has served are the Graham Foundation for the Advancement of the Fine Arts, the Society of Architectural Historians, and the Art Institute of Chicago.
Mr. Kuehn holds a B.E. in Mechanical Engineering (with high honors) from Yale University and received an MBA from Harvard Graduate School of Business.
David Nagle is a Registered Patent Attorney who has been with the Intellectual Property & Technology Service Group since its inception. He holds an advanced engineering degree, and his technical knowledge consistently allows him to better understand his clients’ business needs and processes.
David has extensive experience prosecuting domestic and foreign patent applications covering a wide range of subject matter, including consumer goods, mechanical devices, software and business methods. He also counsels clients on trademark and copyright issues, and he regularly negotiates and prepares licensing agreements and other contracts implicating intellectual property rights. David is recognized as a Certified Licensing Professional (CLP™), a designation which acknowledges licensing professionals who have demonstrated their experience and proficiency in licensing and the commercialization of intellectual property.
Examples of his recent engagements include:
- Serves as outside patent counsel to one of the world’s leading restaurant companies, developing appropriate patent strategies to protect new food products, food preparation methods, and related equipment.
- Developed a comprehensive intellectual property plan that protected a new product line for a leading beverage equipment manufacturer.
- Assisted a developing lighting company in filing patent applications related to its core technology in more than 30 countries, and subsequently prepared and negotiated distributorship and license agreements for its foreign distributors.
Mr. Nagle’s recent presentations include: regular lecturer, “Professional Issues and Current Topics,” Speed Scientific School at the University of Louisville; “Patents, Copyrights, Trademarks & Venture Capital,” Kentucky Bar Association, 16thAnnual Issues for Corporate House Counsel Seminar, with James Seiffert, April 12, 2006; and panelist, “The Power of Angel Investing,” University of Louisville School of Business, May 26, 2005.
Mr. Nagle serves on the Board of Trustees for WLKY- TV’s Spirit of Louisville Foundation and is a member of Holy Trinity Church. David was named to the 2009 “Forty Under 40” list by Business First of Louisville. Prior to joining the firm, Mr. Nagle was an Associate with Wheat, Smith & Beres, which merged into Stites & Harbison in 2000.
Mr. Nagle received a JD, an ME and a BS in Mechanical Engineering from the University of Louisville.
Mandy Wilson Decker is a Patent Attorney and is a member of the Intellectual Property & Technology Service Group. Her practice focuses on intellectual property protection strategy, including counseling clients on infringement, validity and patentability, transfer of intellectual property, patent drafting, and patent prosecution. Contributing to her practice is a scientific background in chemistry and experience with academic and commercial research in the areas of biochemistry, biotechnology, and pharmaceutical sciences. Mandy is currently Chair of Stites & Harbison’s Women’s Initiative, S.W.I.F.T., a member of the firm’s Diversity Committee, and a past member of the firm’s Ethics Committee.
Examples of Ms. Decker’s recent engagements include:
- Developed intellectual property portfolio protection strategies for various research institutions, universities, private companies, and entrepreneurs. Prepared and prosecuted patent applications in a wide variety of chemical, biochemical, pharmaceutical, cosmeceutical, dermatologic, biotechnological, medical, and mechanical arts derived from both academic and commercial research.
- Managed international patent portfolios and prosecution involving applications and patents in regions and countries including Australia, African Union (OAPI), Brazil, Canada, China, Europe, France, Germany, Greece, Hong Kong, India, Ireland, Israel, Italy, Japan, Korea, Liechtenstein, Mexico, New Zealand, Russia, Singapore, South Africa, Spain, Sweden, Switzerland, the United Kingdom, and the United States.
- Assisted in negotiation of agreements to transfer or license intellectual property rights.
Mandy joined the firm after working as a scientific research associate at the University of Kentucky in laboratories housed in the Advanced Science Technology and Commercialization Center. These labs received substantial funding from the National Institutes of Health to conduct research to better understand responses to genotoxic stress, and its implications for treatment and prevention of cancer and age-related conditions. Mandy’s scientific research experience also involved working with Niadyne, Inc., a biotechnology company involved in the research and development of dermatology products, including cosmeceutical and pharmaceutical skin care products to address various health care needs.
Ms. Decker is a frequent author and speaker on scientific and legal topics. Her recent contributions include: Presenter, “Intellectual Property,” Kentucky Innovation & Entrepreneurship Conference, Louisville, KY, June 1, 2012; “U.S. Supreme Court kicks Myriad, the Gene Patent Case, back to the Federal Circuit for consideration in view of the Mayo Opinion,” Stites & Harbison, PLLC, Client Alert, March 27, 2012; “U.S. Supreme Court decision gives rise to new challenges for patent protection in the field of personalized medicine and beyond,” Stites & Harbison, PLLC, Client Alert, March 21, 2012; “America Invents Act: What’s New in the New Patent Act?,” Medical News, December 2011; lecturer, “Patent Prosecution,” University of Kentucky, College of Law, Intellectual Property Law, November 17, 2011; lecturer, “Intellectual Property,” University of Kentucky, Scholars in Engineering and Management (SEAM), Lexington, KY, October 27, 2011; “Protecting Your Intellectual Property,” University of Kentucky Von Allmen Center for Entrepreneurship and Kentucky BioAlliance, Lexington, KY, October 13, 2011; “Developing and Integrating a Comprehensive IP Strategy in a Global Marketplace,” Kentucky BioAlliance (KSTC), Louisville, KY, June 21, 2011; and “Mutant court case? The uncertain future of innovation for DNA-based technologies, from diagnostics to vaccine production tools,” Medical News, Louisville, KY, May 2010.
Mandy was named to the “Forty under 40” list by Business First of Louisville in 2008. In 2011 she was named one of the Partners in Health Care People to Watch by Business First of Louisville, and in 2012 she was named a Partner in Health Care by Business First of Louisville for her contributions to the Life Sciences Community. She is a member of the Board of Directors of Kentucky BioAlliance and she serves on the Annual Campaign Committee of the Legal Aid Society.
Ms. Decker is admitted to practice in Kentucky, the U.S. District Courts for the Eastern District and Western Districts of Kentucky, the United States Patent and Trademark Office and the U.S. Court of Appeals for the Federal Circuit.
Ms. Decker received her JD and BS in Chemistry from the University of Kentucky.
Terry Wright is an attorney with Stites & Harbison based in the Louisville office. He is a Registered U.S. Patent Attorney and a member of the Intellectual Property & Technology Service Group. His practice focuses on patent-related aspects of intellectual property, including patent drafting, patent prosecution and counseling clients on infringement, validity and patentability.
Contributing to his practice is a background in life sciences and experience with academic research in the areas of cardiovascular biology, molecular and cellular biology, pharmacology and biotechnology. Currently he counsels a number of companies and Technology Transfer and Licensing Offices of various universities regarding strategies for protecting patent-based intellectual property.
Examples of Mr. Wright’s recent speaking engagements and publications include:
- “Developing and Integrating a Comprehensive IP Strategy in a Global Marketplace,” Kentucky BioAlliance and Kentucky Science and Technology Corporation (KSTC), Louisville, KY, June 2011
- “International Patent Prosecution and PCT Practice,” Kentucky BioAlliance Intellectual Property Forum, Louisville, KY, June 2011
- “Protecting Intellectual Property,” Kauffman FastTrac Tech Venture Program, University of Louisville, May 2011
- Co-moderator, “Biotechnology Patent Prosecution,” Association of University Technology Managers Annual Meeting, Las Vegas, NV, March 2011
- “Intellectual Property Protection in a University Setting,” Marshall University, August 2010 & January 2011
- “Patent Law Ethics: The Changing Landscape of Materiality,” Louisville Bar Association, Louisville, KY, June 2010
- “Innovation and the Patentability of Natural Phenomena,” Second Annual Conference in Innovation and Communications Law, Louisville, KY, August 2009
- Co-moderator, “The Developing Landscape of Biotechnology Patent Law,” Association of University Technology Managers Annual Meeting, Orlando, FL, February 2009
- “Patent Law 101 for the Health Care Industry,” Louisville Bar Association, May 2008
- Brown M, McGuinness M, Wright T, Ren X, Wang Y, Boivin GP, Hahn H, Feldman AM, Jones WK. “Cardiac-specific blockade of NF-κB in cardiac pathophysiology: differences between acute and chronic stimuli in vivo,” Am J Physiol Heart Circ Physiol. 289(1):H466-76 (2005)
- “The Role of NF-κB in Myocardial Ischemia Reperfusion Injury,” Keystone Symposia, Keystone, Colo., March 2002
- “Ablation of Myocardial NF-κB signaling in a Mouse Model of TNF-α overexpression,” Keystone Symposia, Keystone, Colo., March 2002
Prior to joining Stites & Harbison, Mr. Wright worked as a scientific research associate in laboratories at both the University of Cincinnati and the University of Louisville.
Mr. Wright is a member of the Association of University Technology Managers (AUTM). He has also served as Chair of the Louisville Bar Association, Intellectual Property Section. In addition to being a Registered U.S. Patent Attorney, Mr. Wright is admitted to practice in Kentucky.
Mr. Wright received a JD, an MS in Pharmacology and Toxicology, and a BS in Biology form the University of Louisville.
Josh is a Co-Founder and CSO of RowdMap. RowdMap’s Health Profit Intelligence platform creates Simple Growth, Performance & Value for Health Plans, Providers, Hospitals & Nursing Homes. Before co-founding RowdMap, Josh founded Sprigley (acquired by Eliza Corporation, 2008), a health engagement platform and data/analytic system that quantified qualitative data, while creating socio-graphic and psychographic metrics that measured and predicted interactions and interventions’ outcomes and impact. While at Eliza he created powerful new offering, which saw Eliza win accolades such as a Business Week Innovation award and named one of Entrepreneur Magazine’s 10 Companies to Watch in Health Care then he played a central role in the sale of a major equity investment in Eliza (Parthenon Capital, 2011). Josh received a Fulbright to the Sorbonne’s Institute for Advanced Studies (EPHE), an interdisciplinary think tank where he began exploring quantifying qualitative data, behavior change and complex systems. He’s served as an industry expert on technology and innovation, data & analytics and public data access to the Department of Health and Human Services, the Centers for Medicare and Medicaid Services, Office of National Coordinator & National Committee on Vital and Health Statistics, lectured at Harvard, Johns Hopkins, WHITE, WHIT, SXSW, etc.
Alex Frommeyer is a Co-Founder & CEO of Beam Technologies. His company seeks to embed sensors into your everyday life.
Their first product, the Beam Brush, is the worlds first connected toothbrush. Alex has experience in developing and commercializing digital health hardware. His company was a participant in Rock Health’s fourth class. They have won several awards including being a CTIA Emerging Tech finalist mHealth 2012, winning a Vogt Award in 2011, and being named one of the GLI Hot Dozen 2011.
Chris Hogg is a Health 2.0 advocate, tech enthusiast, researcher and analyst of all things healthcare. He is interested in how technology is changing the healthcare landscape, specifically the impact it has on behavior change. Chris is passionate about the value and utility of new forms of health data, and the changing relationship between physician and patient.
In October 2011, Chris co-founded 100Plus, a personalized health prediction startup using data analytics and game mechanics to show how small changes in behavior can lead to an overall healthier and longer life, with funding from Founders Fund, Greylock Partners and Felicis Ventures. In February 2013, 100Plus was acquired by Practice Fusion, the nation’s largest physician-patient community. Chris is now the Head of Data Science at Practice Fusion where he is developing new ways to use de-identified clinical data as the foundation for consumer and physician facing products.
Chris has been a guest lecturer at Stanford University and a speaker at TEDx Silicon Valley on the topics of user-generated health and the future of health data. Chris holds a Degree in Molecular and Cell Biology from Brown University and an MBA from The University of Chicago.
Wil Yu currently advises a number of organizations, public and private, on strategies related to new healthcare markets driven by changing policy and technology environments. He is engaged in several collaborations designed to foster both national care delivery transformation and increased patient engagement. He also works closely with a number of health IT and healthcare services startups.
Recently, he founded a non-profit foundation dedicated to supporting healthcare innovation adoption and diffusion efforts. He is also an editor for a new academic journal focused on care delivery science and technology and serves part-time as an Advisor to the Civic Innovation Office within the City of San Francisco.
Previously at the U.S. Department of Health and Human Services, he led nationwide healthcare innovation efforts designed to facilitate the implementation of policies for both the HITECH and Affordable Care Act within the private sector. At the Office of the National Coordinator for Health IT (ONC), he headed several innovation grant programs including the “Investing in Innovations” (i2) and Strategic Health IT Advanced Research Projects (SHARP) programs–both funding breakthrough developments in health information technology and the achievement of Meaningful Use.
Mr. Yu served as a Senior Advisor at the CMS Innovation Center (CMMI), promoting engagements at the intersection of technology, care delivery, and reimbursement innovation, especially Accountable Care Organizations. In collaboration with the White House Startup America initiative, he directed the DC-to-VC effort—promoting investments in health information technology infrastructure amongst early stage investors. As a former equity analyst and investment banker he has covered a wide range of markets within healthcare delivery and related services; participating in various equity and M&A transactions.
Mr. Yu graduated from the University of California, Berkeley – School of Public Health with a Masters in Health Policy and Management.
Joe Steier, III is the President & CEO and Co-Founder of Signature HealthCARE, one of the nation’s leading long-term care providers with 75 facilities in six states. The mission and vision of the organization is to “radically change long term care forever” through its three foundational pillars – Spirituality, Learning and Intrapruenership. SHC has earned many national accolades including Best Places to Work, Inc 5000, and the U.S. News & World Report, Best Nursing Homes list.
The company also has launched multiple spins off organization including Silver Angels, Integritas, SHC Furniture Factory, Innovate LTC, while various numerous philanthropic endeavors to aid its own employees and the communities it serves.
Signature helped catapult Louisville into the national spotlight as a leader in innovation in aging care after it partnered with the University of Louisville to launch the International Center for Long Term Care Innovation, a business accelerator dedicated to bringing new aging care products, services and technologies to market. Aging care is now among Louisville’s dominant economic clusters, a feat that has earned the industry and the city coverage in the New York Times, The Washington Post and other renowned publications.
A Louisville native, Joe has two decades’ professional experience invested in health care. He has an insatiable appetite for knowledge and holds a Bachelor’s degree in Accounting from Bellarmine University, a CPA license, an MBA with Healthcare Emphasis from the University of Miami, and Masters and Doctorate degrees in Education from the University of Pennsylvania/Wharton School of Business while winning many personal leadership awards as well.
Dr. Massey is President and Chief Operating Officer of SureGene. He is an academic scientist and business professional with a proven track record of leadership success. He has twenty-two years experience in executive management, operations, basic research, clinical affairs, regulatory affairs and marketing, in the pharmaceutical and biotechnology-related industries. He has played a leadership role in the successful filing of 28 IND applications and 8 NDA applications. Dr. Massey is the inventor of over 200 new chemical entities designed as putative antipsychotic agents.
Dr. Massey comes to SureGene from Vanderbilt University where he held the Jack Martin Research Professorship in Psychopharmacology and performed research on the biological basis for antipsychotic drug action in the laboratory of Dr. Herbert Y. Meltzer.
Dr. Massey earned his PhD in Pharmacology from the University of Arkansas for Medical Sciences and his BS in Biology from the University of Central Arkansas and completed the undergraduate Zoology Program at the University of Arkansas.
Vickie Yates Brown is the President and CEO of Nucleus, Kentucky’s Innovation Center, LLC, a subsidiary of the University of Louisville Foundation, which serves as the economic development arm of the University of Louisville. Vickie is also responsible for securing and administering tax increment financing for the University’s three research parks. The most recent TIF approval for the Main Campus Research Park is the largest TIF ever approved in the US. Additionally, Vickie serves as a Special Assistant to James Ramsey, President of the University of Louisville, on health care and economic development issues. Vickie is a member of the law firm of Frost, Brown Todd LLC where she practices in the Louisville, Kentucky office and serves as the co-chair of the Firm’s Health Law Practice Group. Vickie is a magna cum laude graduate of Georgetown College and a graduate of the University of Kentucky School of Law. Vickie is also a certified mediator.
Vickie writes and lectures often on health law topics, particularly the Affordable Care Act and the privacy and security of health information. She has received a number of honors, including selection in The Best Lawyers of America, Kentucky Super Lawyer and The Guide to the Leading Healthcare Lawyers in America. Vickie is the Immediate Past Chair of the ABA Health Law Section and appointed by the ABA President to serve as a member of the Standing Committee on Government Affairs and an Emeritus member of the ABA Standing Committee on Medical Professional Liability. Also, Vickie has also served as co-chair of the ABA Task Force to draft comments concerning proposed and final DHHS HIPAA regulations and currently serves on the BNA Health Law Reporter Advisory Board. Vickie was recently selected as the 2013 Woman of Influence by Louisville’s Business First Newspaper and she also received the 2013 Martha Layne Collins Leadership Award.
Vickie has held a number of government appointments, including member of the National Institutes of Health’s Advisory Council for the Human Genome Research Institute and the Advisory Council of the National Institute of Diabetes, Digestive and Kidney Diseases. She also serves as Governor Beshear’s privacy and security expert on the Kentucky Health Information Exchange Coordinating Council.
John is the founder and CEO of InnovateLTC, a for-profit accelerator focused on disruptive products, service models and technologies that enhance both the quality of life and care for the global aging population. John is a serial entrepreneur, founding partner of Commonwealth Leverage Group and past president of AIC acquired by Allscripts Healthcare. In 2004 John received the Ernst Young Entrepreneur of the Year, he was also with Coopers and Lybrand after graduating from UK. He recently completed his MBA in Healthcare at the University of Miami in Florida and in 2012 co-authored; Accountable Care, Bridging The Health Information Technology Divide.
Charles began his career with Humana in 1994 as a management trainee. During his 19 years with the company, Charles has held a variety of roles, including Network Development Specialist, Manager of Ancillary Networks, Director of Specialty Products, Director of Venture Capital, and currently Vice President of Corporate Development.
For the last decade, Charles has played a key role in Humana’s strategic investment activities. Serving as part of a team that reinvigorated Humana’s M&A function, he has led a group that had deployed more than $4 billion of capital. Connected closely to Humana’s strategy and operations leadership, Charles has consistently collaborated with key stakeholders to acquire assets that not only further Humana’s strategy but also fit within the company’s operating model.
Charles’ team led efforts to make major investments in Humana’s provider development initiative (Metcare, Concentra) as well as key capabilities within Humana’s integrated care model (SeniorBridge, Certify).
Charles received his Bachelor’s Degree from the University of Texas and his Master’s Degree from the University of Louisville. A Kentucky native, Charles lives in Louisville with his wife and two daughters.
Gregory Murdock is a partner in Saunders Murdock Associates, a super angel partnership that invests in early stage technology and life science companies. In this role, Greg is actively involved in many of our portfolio companies where he works with CEO’s on strategy, fundraising and communications . Portfolio companies include Bioscale, a proteomics platform company; Apellis, an immunology drug discovery play; NX Pharmagen, a molecular diagnostics company; Carrot Medical, a systems integrator in interventional cardiology; Summit Biosciences, a drug delivery platform technology: and Vivorte, an orthopedic company. Greg is a cofounder of Boardroom Events, an organizer of hosted events, and ART LLC, a natural resource company. Greg lives in Boston where he has an active network and multiple portfolio companies.